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ABSTRACT
Amyloids are the products of protein misfolding into fibril-like structures, which
take place in human tissues and organs, including the human brain, heart, liver, and
pancreas. As the deposition of amyloid fibrils usually leads to the dysfunction or death of
cells, the formation of amyloid is associated with more than 20 human diseases, such as
Alzheimer’s, Parkinson’s, and type 2 diabetes. Understanding how soluble peptides to form
amyloid fibrils and how to modulate those amyloid aggregation are central to the design of
rational therapeutic strategies against those diseases. Increasing experiments suggest that
amyloid peptides can undergo liquid-liquid phase separation (LLPS) before the formation
of amyloid fibrils. However, the exact role of LLPS in amyloid aggregation at the
molecular level remains elusive. Here, the LLPS and amyloid fibrillization of a coarsegrained peptide, capable of capturing fundamental properties of amyloid aggregation over
a wide range of concentrations was investigated in Discrete Molecular Dynamics (DMD)
simulations. I also studied the different biomolecules and nanoparticles interactions with
amyloid proteins. This study provides a unified picture of amyloid aggregation for a wide
range of concentrations within the framework of LLPS and the potential mitigation of
amyloid aggregations, which may help us better understand the etiology of amyloid
diseases and disease therapist for human diseases.
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CHAPTER ONE
AMYLOID AGGREGATION AND MODULATION
Amyloid and Human Diseases
Amyloid aggregation, a fundamental property of proteins and peptides,1 corresponds to the
self-assembly of misfolded proteins or peptides into insoluble fibrillar aggregates.2–4
Amyloids are associated with a long list of human diseases, including neurodegenerative
Alzheimer’s with feathered protein amyoid-beta (amyloid- β), Parkinson’s with feathered
protein Alpha synuclein (αS), and type 2 diabetes5–7 (T2D) with feathered protein human
islet amyloid polypeptide (IAPP, a.k.a. amylin). Despite drastic differences in the
sequences and structures of aggregating proteins, the final aggregates share a common
characteristic cross-β

conformations,

where

multi-layer β-sheets

with

perpendicular to the fibril axes are forming the amyloid core as shown in Fig. 1-1.

Figure 1-1. Amyloid fibril structure.
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strands

The deposition of human IAPP amyloid aggregates in the pancreas is the hallmark of T2D.
IAPP is a 37-residue peptide hormone co-stored and co-secreted with insulin from
pancreatic β-cell islets. IAPP is synthesized from a 67-residue precursor peptide, proIAPP,
by proteolysis and posttranslational modifications.8–10 Both IAPP and insulin are regulated
by similar factors with a common regulatory promoter motif.11 IAPP functions as a
synergistic partner of insulin to control the blood glucose level by slowing down gastric
emptying, inhibiting digestive secretion, and promoting satiety.12,13 IAPP is also known to
play a role in bone metabolism along with calcitonin and calcitonin gene-related peptides.14
Insulin resistance in T2D leads to increased production of insulin and also IAPP by β-cells
because of their shared synthesis and secretion pathways. Since IAPP is one of the most
amyloidogenic peptides known, over-production of IAPP in β-cells promotes the
accumulation of toxic aggregates. Other studies also suggested that insufficient process of
proIAPP and accumulation of intermediately processed peptides might promote the
formation of amyloid fibrils, but the detailed molecular mechanisms remain unclear. The
disease progression is marked by β-cell death and loss of β-cell functions, resulting in
insulin deficiency and diabetic dependence on external insulin sources.
Alpha synuclein (αS) is a major component of Lewy bodies and neurites, the intracellular
protein aggregates first identified by Spillantini et al. in 199715 and hallmarks of
Parkinson’s disease, Parkinson’s disease dementia and dementia with Lewy bodies. αS is
a 140-residue small protein highly concentrated in presynaptic terminals,16 making up as
much as 1% of all proteins in the cytosol of brain cells. Small traces of αS are also found
in the heart, gut,17 muscles and other tissues. In the intraneuronal space, αS assumes an

2

equilibrium between an unfolded monomeric conformation and a membrane-bound state
that is rich in alpha helices.18 The precise physiological role of αS is unclear, but is relevant
to the modulation of neurotransmitter dopamine release, ER/Golgi trafficking, and synaptic
vesicles.19 The membrane-bound αS influences lipid packing and induces vesicle clustering
through physical and physicochemical interactions, while αS in the multimeric form has
been shown to promote soluble N-ethylmaleimide-sensitive factor attachment protein
receptor complex assembly during synaptic exocytosis.18 Aggregated αS mediates
dopaminergic neurotoxicity in vivo.20 However, the precise mechanisms by which αS lends
toxicity to host cells remain unclear. Compared with the ambiguous pathology of αS, the
neuritic pathology of β and γ synuclein homologs does not appear widespread, and both
neuroprotective and neurotoxic potentials of β synuclein have been reported.21
The formation of insoluble amyloid fibrils is known to be a complex multistep process,
involving the formation of soluble oligomers, the nucleation of β-rich aggregates or
protofibrils, and the elongation and bundling of protofibrils into mature fibrils. Increasing
evidence supports the toxic oligomer hypothesis, where soluble low molecular weight
oligomers corresponding to the aggregation intermediates are found more cytotoxic than
the final fibrils. Therefore, understanding the detailed aggregation pathways and the
structure and dynamics of various aggregation intermediates is important for the design of
anti-amyloid therapeutic strategies.
Amyloid Aggregation
Typical amyloid aggregation kinetics follows a sigmoidal curve (Fig. 1-2), featuring a rapid
growth after the initial lag phase and then reaching a plateau due to saturation. The
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nucleation step is initiated by the formation of critical oligomers of the amyloidogenic
protein or peptide monomers (a natively folded protein usually undergoes partial unfolding
into an aggregation-prone state). With the addition of more monomers, the oligomers
elongate into proto-fibrils, corresponding to a rapid increase in aggregates. Mature fibrils
are formed by bundling of multiple proto-fibrils. The nucleation-dependent fibrillization
processes are usually described by the primary, secondary nucleation and/or
fragmentation.22,23 The primary nucleation denotes the ab initio formation of a critical
nucleus – the minimalist fibril or protofibril – from monomers; the secondary nucleation
corresponds to the formation of an aggregation nucleus by monomers adsorbed on the
lateral surface of newly formed fibrils; and the fragmentation of fibrils increases the active
elongation sites for fibril growth via monomer addition. Fitting aggregation kinetics at
different concentrations with closed-form analytical solutions under different nucleation
scenarios has been successful for delineating the mechanisms of aggregation.22–24
Understanding the amyloid aggregation is of great importance to unrevealing the
mechanism of neurodegenerative disease.

Figure 1-2. Sigmoidal amyloid aggregation kinetics.
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Modulating Amyloid Aggregation
The amyloid aggregation can be modulated by biomolecules or nanoparticles. Since the
introduction of biomolecules or nanoparticles can interfere on each of amyloid aggregation
steps depending on the affinity of various molecular species along the aggregation
pathway.
Several biomolecules, including serum amyloid P (SAP) component,25 apolipoprotein E
(ApoE),26 and glycosaminoglycans (GAGs), in particular heparan sulfate proteoglycans,27
have been shown to associate with IAPP amyloid deposits in vivo. GAGs are also known
to enhance fibrillation of IAPP,28,29 and can promote aggregation of incompletely
processed IAPP.30 Secretory chaperones and serum albumin have also demonstrated some
capacity in preventing IAPP fibrillation in vitro.29,31 However, protein association with
IAPP does not necessarily affect residual IAPP-mediated cytotoxicity; in the cases of ApoE
and GAGs, only the latter is implicated in IAPP toxicity.32,33
IAPP is synthesized in pancreatic β-cells and co-released with insulin to blood circulation
for glycemic control.1 IAPP fibrils and plaques, however, appear in the extracellular space
of the Langerhans suggesting a role of cell membranes in inducing aberrant IAPP
aggregation. Indeed it has been shown in the literature that cell membranes as well as lipid
vesicles generally promote IAPP aggregation,7-18 as also observed for amyloid-β and αsynuclein in neurodegenerative disorders.19,20 Conversely, IAPP disrupts membrane
integrity through lipid extraction or pore formation.12,14,18,19 On the molecular level, twhe
binding between IAPP and a lipid interface is initiated by the N-terminus of the peptide,
through electrostatic interaction with the anionic lipids and facilitated by hydrophobic
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interaction engaging the lipid bilayer and the amphiphilic peptide oligomers, protofibrils
and fibrils.8-11,13
Amyloid aggregation can also be modulated by nanoparticles. Javed et al. 34 coated carbon
nanotubes (CNTs) with fragmented β-lactoglobulin amyloid nanofibrils and demonstrated
both in vitro and in vivo that the hybrid CNTs could mitigate the aggregation-associated
cytotoxicity of both IAPP in type-2 diabetes and amyloid-β (Aβ) in Alzheimer's disease.
In addition to pre-formed amyloid fibrils as the functionalization agents, the adsorption and
self-assembly of amyloid polypeptides onto the surface of carbon nanomaterials were also
studied both in vitro and in silico. Using in situ atomic force microscopy (AFM),
Kowalewski and Holtzman showed that Aβ1-42, when deposited on graphite, formed
ordered elongated β-sheets with extended conformations. Combining AFM and molecular
dynamics (MD) simulations, Arce et al. 35 suggested that a strong interaction between Aβ1742

and highly ordered pyrolytic graphite (HOPG) forced the formation of amyloid filaments

following graphite’s hexagonal lattice symmetry, which was validated in simulations with
preassembled Aβ17-42 filament on HOPG resulting into a stable U-shaped β-strand-turn-βstrand structure along the graphene surface. Lin et al. 36 observed the rapid adsorption of
Aβ1-40 on single-walled carbon nanotubes (SWCNTs) surfaces and subsequent inhibition
of Aβ amyloid aggregation into toxic oligomers and mature fibrils using both biophysical
characterization and coarse-grained MD simulations.
During my PhD study, I applied the discrete molecular dynamics (DMD) simulation to
study the amyloid aggregation of different feathered proteins, and their interactions with
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different nanoparticles. Here is a list of my publications of my PhD study. For his
dissertation, I only include parts of my study, focusing on the amyloid aggregation in the
context of liquid-liquid phase separation (LLPS), and modulating the amyloid aggregation
by using serum proteins (e.g. lysozyme and α-lactalbumin), lysophosphatidylcholine
(LPC), and CNMs (e.g. carbon nanotube and graphene). This study provide a unified
picture of amyloid aggregation for a wide range of concentrations, which may give a new
insight to understanding neurodegenerative disease mechanism and potentially the
therapist.
List of first and co-authored publications:
1. N Andrikopoulos, Z Song, X Wan, A M Douek, I Javed, C Fu, Y Xing, et. al.,
“Inhibition of Amyloid Aggregation and Toxicity with Janus Iron Oxide
Nanoparticles”, Chemistry of Materials, 2021
2. Y Xing, A Nandakumar, A Kakinen, Y Sun, TP Davis, PC Ke, F Ding, “Amyloid
aggregation under the lens of liquid–liquid phase separation”, The Journal of
Physical Chemistry Letters., 2021
3. Y Xing, Y Sun, B Wang, F Ding, “Morphological Determinants of Carbon
Nanomaterial-Induced Amyloid Peptide Self-Assembly”, Frontiers in chemistry,
2020
4. A Nandakumar, Y Xing, et.al.,“Human plasma protein corona of Aβ amyloid and
its impact on islet amyloid polypeptide cross-seeding”, Biomacromolecules, 2020
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5. A Kakinen, Y Xing, et.al., “Single-molecular heteroamyloidosis of human islet
amyloid polypeptide”, Nano letters, 2019
6. I Javed, G Peng, Y Xing, et.al., “Inhibition of amyloid beta toxicity in zebrafish
with a chaperone-gold nanoparticle dual strategy”, Nature communications, 2019
7. Y Sun, A Kakinen, Y Xing, et.al., “Amyloid Self‐Assembly of hIAPP8‐20 via the
Accumulation of Helical Oligomers, α‐Helix to β‐Sheet Transition, and Formation
of β‐Barrel Intermediates”, Small, 2019
8. Y Sun, X Ge, Y Xing, B Wang, F Ding, “Nucleation of β-rich oligomers and βbarrels in the early aggregation of human islet amyloid polypeptide”, Biochimica
et Biophysica Acta (BBA)-Molecular Basis of Disease, 2018
9. Y Sun, X Ge, Y Xing, B Wang, F Ding, “β-barrel oligomers as common
intermediates of peptides self-assembling into cross-β aggregates”, Scientific
Report, 2018
10. E Pilkington, O Gustafsson, Y Xing, et.al., “Profiling the serum protein corona of
fibrillar human islet amyloid polypeptide”, ACS nano, 2018
11. E Pilkington, Y Xing, B Wang, A Kakinen, M Wang, T P Davis, F Ding, P Ke,
“Effects of protein corona on IAPP amyloid aggregation, fibril remodeling, and
cytotoxicity”, Scientific Report, 2017
12. Y Xing, E Pilkington, M Wang, C J Nowell, A Kakinen, Y Sun, B Wang, T P
Davis, F Ding, P Ke, “Lysophosphatidylcholine modulates the aggregation of
human islet amyloid polypeptide”, Physical Chemistry Chemical Physics, 2017
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CHAPTER TWO
DISCRETE MOLECULAR DYNAMICS
A detailed description of the DMD algorithm can be found elsewhere.37–39 Briefly, interatomic interactions in DMD are governed by square well potential functions. Neighboring
interactions (such as bonds, bond angles, and dihedrals) are modeled by infinitely high
square well potentials. During a simulation, an atom’s velocity remains constant until a
potential step is encountered, where it changes instantaneously according to the
conservations of energy, momentum, and angular momentum. Simulations proceed as a
series of such collisions, with a rapid sorting algorithm employed at each step to determine
the following collision. The difference between DMD and traditional molecular dynamics
is in the in-teraction potential functions. Approximating the continuous potential functions
with step functions of pair-wise distances, DMD simulations are reduced to event-driven
(collision) molecular dynamics simulation. The sampling efficiency of DMD over
traditional molecular dynamics is mainly due to rapid processing of collision events and
localized updates of collisions (only collided atoms are required to update at each collision).
At an adequately small step size, the discrete step function approaches the continuous
potential function, and DMD simulations become equivalent to traditional molecular
dynamics.

9

Figure 2-1. The All-Atom Protein Model. (A) Schematic diagram for the all-atom protein
model. Only two consecutive residues are shown. The solid thick lines represent the
covalent and the peptide bonds. The thin dashed lines denote the effective bonds, which
are needed either to fix the bond angles, model the side chain dihedral angles, or maintain
the planarity of the peptide bonds. (B) Parameterization of the bonded interactions for
representative atom pairs. The first column shows the distribution of the distances in serine,
between N-Cα, N-Cβ, and N-Oγ, respectively. The second column shows the corresponding
histogram for the distribution of each atom pair. The third column shows the resulting
constraint potentials schematically. For bonds (e.g., N-Cα) and bond angles (e.g., N-Cβ),
the left and right boundaries of the constraint potential correspond to d − σ and d + σ,
respectively. Here, d is the average length and σ is the standard deviation of the distance
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distribution. (C) Parameterization of nonbonded interactions in all-atom DMD. The
continuous red line corresponds to the VDW and solvation interaction between two carbon
atoms. The black step function is the discretized potential for DMD. (D) A schematic for
the hydrogen bonding interaction between hydrogen Hi and acceptor Aj. Atom Di is the
donor and Xj is the heavy atoms directly bonded to Aj. Aside from the distance between
hydrogen and acceptor dHA, we also assessed the auxiliary distances of dDA (distance
between atoms Di and Aj) and dHX (distance between atoms Hi and Xj).
All-Atom Protein Model
We use a united-atom representation to model proteins, in which all heavy atoms and polar
hydrogen atoms of each amino acid are included (Fig. 2-1A). In order to maintain the
protein back-bone and side chain geometries, we introduce three types of bonded
constraints between neigh-boring atoms: (1) consecutive atoms (i, i+1) covalently bonded;
(2) next-nearest neighbors (i, i+2) under angular constraints; and (3) atom pairs (i, i+3)
linked by dihedral interactions. For covalent bonds and bond angles, we use a single-well
potential (Fig. 2-1B) with two parameters: effective bond length dAB, and its variance, σAB.
The dihedral interactions are modeled by multistep potential functions of pair-wise distance
as introduced by Ding et al.,40 which is characterized by a set of distance parameters, {dmin,
d0, d1,d2, dmax}(Fig. 2-1B). We obtain these parameters by sampling the corresponding
distance distribution ina nonredundant database of high-resolution protein structures.
These bonded interaction parameters are listed in Table S1. For the nonbonded interactions,
we include the VDW, solvation, and hydrogen bond interactions:41
VDW and Solvation Interactions
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The VDW and solvation interactions are pair-wise functions of distances, while the
hydrogen bond interactions are angular and distance dependent, making them multibody
interactions. Therefore, we combine the VDW and solvation together as the pair-wise
interactions. We use a standard 12-6 Lennard-Jones potential to model the VDW
interactions: 𝐸 𝑉𝐷𝑊 = ∑𝑖,𝑗>𝑖 4𝜀𝑖𝑗 [(𝜎𝑖𝑗 /𝑟𝑖𝑗 )12 − (𝜎𝑖𝑗 /𝑟𝑖𝑗 )6 ]. Here, the VDW radii σij and
interaction strengths 𝜀 ij betweem atoms i and j are taken from CHARMM19 force field:
𝜀𝑖𝑗 = √𝜀𝑖 𝜀𝑗 ; 𝜎𝑖𝑗 = 𝜎𝑖 +𝜎𝑗 . We use the Lazaridis-Karplus42 solvation model:
2Δ𝐺𝑖

𝐸 𝐿𝐾 = ∑𝑖,𝑗>𝑖[− 4𝜋

2
√𝜋𝜆𝑖 𝑟𝑖𝑗

2Δ𝐺𝑗

2
exp(−𝑥𝑖𝑗
) 𝑉𝑗 − 4𝜋

2
√𝜋𝜆𝑗 𝑟𝑖𝑗

exp(−𝑥𝑗𝑖2 )𝑉𝑖 ]

𝑥𝑖𝑗 = (𝑟𝑖𝑗 − 1.12𝜎𝑖 )/ 𝜆𝑖 ; 𝑥𝑗𝑖 = (𝑟𝑗𝑖 − 1.12𝜎𝑗 )/ 𝜆𝑗
Here, parameters of reference solvation energy (ΔGfree), volume of atoms(V), correlation
length (𝜆), and atomic radius (σ) are taken from EEF1.42 The discrete potential functions
mimic the continuous potential, 𝐸𝑖𝑗 (𝑑𝑖𝑗 ) = 𝐸𝑖𝑗𝑉𝐷𝑊 (𝑑𝑖𝑗 ) + 𝐸𝑖𝑗𝐿𝐾 (𝑑𝑖𝑗 ) , by capturing the
attractions and repulsions (Fig. 2-1C). We keep the number of steps minimal, since
increasing the number of steps reduces the computational efficiency of DMD. The discrete
potential function is characterized by the hardcore distance, dhc, anda series of potential
steps {di,ei}. Here, di is the distance where potential energy E has a step E(di − 1, di) − E(di,
di + 1) = ei (dhc < d1 < d2 < ••• < dn). We use a cutoff of 6.5 Å as the interaction range between
all atom pairs.
Hydrogen Bonds
We use the reaction algorithm to model the hydrogen bond interaction as de-scribed by
Ding et al.43 Briefly, after the formation of a hydrogen bond, the acceptor (A) and hydrogen
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(H) change their types to A′ and H′, respectively. The interaction potential between an atom
and A(H) can be different from its interaction potential with respect to A′ (H′). Thus, the
formation of a hydrogen bond depends on its neighbors. To mimic the orientationdependent hydrogen bond interaction, we introduce auxiliary interactions in addition to the
distance-dependent interaction between the hydrogen and the acceptor (Fig. 2-1D). The
auxiliary interactions are between the acceptor (A′) and the donor (D), and between the
hydrogen (H′) and the nearest heavy atoms bonded to the acceptor (X). For example, once
the hydrogen, Hi, and the acceptor, Aj(Fig. 2-1D), reach the interaction range, we evaluate
the distances between HiXj and DiAj, which define the orientations of the hydrogen bond.
The total potential energy change, ΔE, between Hi/Aj and other surrounding atoms are also
evaluated before and after the putative hydrogen bond formation :DE=. Here, σk the
other atoms. If these distances satisfy the predetermined range, and the total kinetic energy
is enough to overcome the potential energy change, ΔE, we al-low the hydrogen bond to
be formed, and forbid its formation otherwise. We include all possible interactions between
backbone-backbone, backbone-side chain, and side chain-side chain. The donors include
backbone amide hydrogen atoms and side chain polar hydrogen atoms of His, Trp, Tyr,
Asn, Gln, Arg, and Lys. The acceptors include backbone carbonyl oxygens, sidechain
oxygens of Asp, Glu, Ser, Thr, and Tyr, and the side chain nitrogen of His.
Units in All-Atom DMD
In the all-atom DMD simulations, the units of mass, length, and energy are daltons
(1.66×10-24 g), angstroms (10-10 m), and kcal/mol (6.93×10-22 joule), respectively. Given
the units of mass (M), length (L), and energy (E), the time unit can be obtained as
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[L]√[M]/[E] , which is approximately 50 fs. The temperature unit is kcal/mol·kB or
5.03×102 Kelvin, where kB is the Boltzmann constant.
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CHAPTER THREE
AMYLOID AGGREGATION UNDER THE LENS OF LIQUID-LIQUID PHASE
SEPARATION
Introduction
Amyloid aggregation, a fundamental property of proteins and peptides,1 corresponds to the
self-assembly of misfolded proteins or peptides into fibrillar aggregates with characteristic
cross-β conformations.2–4 Increasing evidence suggests that soluble aggregation
intermediates play more important roles than mature fibrils to the pathology of amyloid
diseases.5,44 Recently, functional amyloids have also been discovered in many life forms
from bacteria and fungi to mammals.45 The potential cytotoxicity of functional amyloid
aggregation can be mitigated via various ways,46 such as minimizing the population of
toxic intermediates with ultrafast fibrillization kinetics.47 Moreover, amyloid fibrils have
also been explored as biocompatible nanostructures for novel applications.48 Typical
amyloid aggregation kinetics follows a sigmoidal curve, featuring a rapid growth after the
initial lag phase and then reaching a plateau due to saturation. On the other hand, increasing
experiments suggest that intrinsically disordered amyloid peptides (IDPs) – e.g., synuclein,49 tau,50,51 islet amyloid polypeptide,52 and TDP-4353 – can undergo liquid-liquid
phase separation (LLPS) before the formation of amyloid fibrils. LLPS, where
biomolecules including proteins and nucleotides coalesce into liquid condensates in
dynamic equilibrium with components in the solution,54,55 plays a crucial role in the
formation and maintenance of “membraneless” organelles, such as nucleoli56 and stress
granules.57 A high concentration of amyloidogenic peptides in the liquid condensates might
promote the formation of toxic oligomers58 and increase the nucleation rates for the
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formation of amyloid fibrils.57,59 However, the exact role of LLPS in amyloid aggregation
at the molecular level is still unknown, and the relationship between LLPS and the
established aggregation nucleation theories also remains elusive.
With the mesoscale system sizes associated with LLPS and amyloid fibrillization,
coarse-grained (CG) simulations are usually applied to elucidate general kinetic and
morphological properties of these biologically important processes. For instance, Mittal
and coworkers applied a slab-geometry based CG computational framework developed for
vapor–liquid transitions to uncover the sequence determinants of LLPS.60,61 Using both CG
particle-based polyampholyte model and the field-theoretic simulation approaches, Shea
and co-workers determined the complete phase diagrams of LLPS by IDPs with different
sequences62. Similarly, many CG models with a wide range of resolution have been
developed to study amyloid fibrillization.23,24,63–72 These CG simulations have offered
useful insights to various aspects of amyloid aggregation, including spontaneous formation
of cross-β aggregates,65,68,69 aggregation kinetics and pathways,63,64,66,67 dynamics of
oligomer population,23,24 fibril chirality,65,72 and thermodynamic phase diagrams.71,73 To
uncover the role of LLPS on amyloid aggregation, it is therefore important to fill the
knowledge gap by examining spontaneous formation of amyloid fibrils within the
framework of LLPS.
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Figure 3-1. CG peptide model. (A) The phase diagram as a function of Flory-Huggins
parameter  and the polymer concentration  features a binodal curve and a phasecoexisting spinodal curve. (B) The CG peptide model with two lowest energy states of
amyloid monomer, corresponding to the fibrillization-prone state β and fibrillizationincompetent state π shown in the inset. (C) Mass-weighted probability distribution of
aggregates with different sizes (upper) and corresponding potential of mean force (lower).
(D) The concentration of the low-density liquid phase as a function of total peptide
concentration. The dashed line denotes the straight line with a slope of 1.
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Here, we applied a CG peptide model capable of capturing general properties of
amyloid aggregation – e.g., nucleated conformational conversion74,75 of peptides to the
aggregation-competent state, sigmoidal aggregation kinetics, and formation of left-handed
fibrils72,76 – to study LLPS and amyloid aggregation. The CG peptide model has been
successfully applied to understand the hetero-aggregation of different amyloid peptides76
and the modulation of amyloid aggregations by chiral nanoparticles.72 Interactions driving
protein self-assembly processes like protein folding and amyloid aggregation should also
play important roles in LLPS. In general, LLPS can be described by a mean-field FloryHuggins theory of polymer solutions,77–79 where a dimensionless parameter  is introduced
to denote the averaged association energy gain between composite amino acids of different
peptides with respect to the thermal fluctuation energy unit kBT. Here, kB is the Boltzmann
constant and T is the system temperature. A typical phase diagram as the function of  and
polymer concentration  features a phase-coexisting binodal curve and a spinodal curve
(Fig. 3-1A).80 Under the aggregation-favoring condition (i.e.,  > C), the system has two
characteristic binodal and two spinodal points at low and high concentrations, BL < SL <
SH < BH. At low concentrations  < BL, the system stays homogenous without phase
separation. When BL <  < SL, the homogenous state of soluble monomers is meta-stable
and the dynamic nucleation of condensate phase occurs. With concentrations SL <  < SH,
the system undergoes LLPS by partitioning into a low-density liquid phase (LDLP) with
the concentration of BL and a high-density liquid phase (HDLP) with the concentration of
BH. Further increase in concentrations results into the dominance of the condensate phase.
Using discrete molecular dynamics (DMD) simulations – a rapid and predictive molecular
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dynamics algorithm,81 we determined the binodal and spinodal concentrations of our CG
peptides at the low concentration regime, BL and SL, which are physiologically relevant.
Only at concentrations above BL, the CG peptides started to form amyloid fibrils in DMD
simulations. Below the spinodal point SL, fibrils were formed via the traditional nucleation
and elongation mechanism, where minimalist fibrils were nucleated from dynamicallyformed transient HDLP condensates, also known as oligomers in the literature. Above SL,
the peptides underwent LLPS first by forming stable oligomers with varying sizes in HDLP,
out of which the nucleated conformational conversion to fibrils took place. The initial fibril
nucleation and growth were governed by the high concentration of peptides in the
condensates. This observation together with the Flory-Huggins theory suggest that the
fibrillization half-times at high peptide concentrations saturate to a constant, corresponding
to the ideal half-time of amyloid aggregation in a homogenous condensate with a high
peptide concentration of BH. With systematic CG simulations, supplemented with a
thioflavin T kinetic assay and transmission electron microscopy, our results offer a unified
picture of amyloid aggregation for a wide range of concentrations pertinent to the
pathophysiologies of amyloid diseases,82 which sheds a new light on the origin of
amyloidosis and may further aid in the development of amyloid-based novel composite
materials.83
Results and Discussion
The 11-bead CG peptide model can adopt either the fibrillization-incompetent πstate representing random coil or helical conformations, or the fibrillization-prone β-state
representing β-sheet conformation (Fig. 3-1B). Each peptide has two hydrogen bond
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donors and two acceptors. Only in the β-state, the CG peptide can continuously grow into
long fibrils by forming parallel in-registered β-sheets stabilized by hydrogen bonds. We
assigned the π-state with a lower energy than the β-state (ΔEβ < ΔEπ) to account for the
observations that amyloid peptides and proteins have to undergo conformational changes
to form amyloid fibrils and the high-energy conformation of an individual peptides in
fibrils is stabilized by extensive backbone hydrogen bonds and side-chain contacts with
neighboring peptides. The amyloid aggregation kinetics of our CG peptides could be
controlled by adjusting the energy barriers of the π- and β-states. For example, the
oligomerization/LLPS process could be decoupled from the fibrillization process with
ΔEπ >> ΔEβ and ΔEπ >> kBT, such that the fibrillization-prone β-state is effectively
eliminated and the peptide becomes non-amyloidogenic.
Liquid-liquid phase separation of the CG peptide
We first studied the CG peptide self-assembly dynamics over a wide range of
concentrations in NVT DMD simulations (Methods). The non-amyloidogenic CG peptide
was used to separate the initial liquid-liquid phase separation from fibrillization.49–53 For
each concentration, 100 independent simulations were performed, starting with
randomized initial configurations in the position and momentum space. After reaching
equilibrium, the mass-weighted aggregate size distributions were calculated with time and
ensemble averages (upper panel, Fig. 3-1C). Higher peptide concentrations resulted into
greater probabilities to observe large size aggregates, consistent early computational
studies of peptide oligomerization.84,85 The corresponding potential of mean force (PMF,
or the effective free energy) as a function of aggregate size (lower panel, Fig. 3-1C) pointed
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to a free energy barrier at the size of ~6-7, separating monomers (i.e., the LDLP) and higher
molecular weight aggregates (i.e., the HDLP condensates or oligomers). Aggregates
comprised of less than 7 peptides were unstable almost independent of the total peptide
concentrations and were subject to dissociation. Therefore, our results indicated 7 as the
size of critical LLPS nucleus for the formation of HDLP condensates of the CG peptide.

Figure 3-2. Snapshots along the simulation trajectory of a pre-formed 50-mer (i.e., the
high-density liquid phase) at BL = 10.4 mM at different times. The peptides are shown in
stick representation. The pre-formed oligomers rapidly dissociated into non-interacting
monomers, i.e., the low-density liquid phase.
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Figure 3-3. Snapshots along a simulation trajectory of 25 mM at different times. At the
beginning, peptides in LDLP and HDLP are shown in orange and purple, respectively. As
the simulation time increases, the two phases co-exist with dynamic exchanges of peptides
observed.

We included peptides in the small unstable oligomers formed by dynamic collisions
with less than 7 peptides together with monomers to the LDLP and plotted the
corresponding peptide concentration, CLDLP, as a function of total concentration,  (Fig. 31D). With the increase of total peptides, CLDLP initially increased and reached a maximum
at  ~ 25.0 mM and then gradually decreased. In the Flory-Huggins polymer solution
theory, the spinodal curve corresponds to the inflection points of free energy, F, with
respect to the total peptide concentration – i.e., the second-order derivative equals to zero,
d2F/d2 = 0.80 Since the chemical potential is the first-order derivative of the free energy,
 = dF/dN  dF/d for an NVT system, spinodal points also correspond to extremals of 
with the first-order derivative equal to zero. On the other hand, the chemical potential of
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the solute for the diluted LDLP is related to the logarithm of the solute concentration,  =
kBTln(CLDLP) + o, where o is a constant. Since the logarithmic function is monotonic, the
extremals of  and CLDLP coincide with each other. Therefore, the maximal point of CLDLP
as a function of  in Fig. 3-1D corresponded to the spinodal point, SL ~ 25.0 mM. At low
concentrations, CLDLP was close to  with deviations larger than 5% starting from  ~10.4
mM. In addition, the concentration of CLDLP at high concentrations of  was approaching
~10.4 mM asymptotically. Therefore, the binodal point BL was ~10.4 mM. Indeed, a preformed large aggregate at BL rapidly dissociated into monomers, i.e., the LDLP (Fig. 32). At SL, LDLP and HDLP coexisted with frequent exchange of peptides between the two
phases (Fig. 3-3). We note that the apparently high values of peptide concentrations was
due to the minimal size of the CG peptide model. With longer sequences (or the degree of
polymerization) and larger dimensions, the binodal and spinodal concentrations of
amyloidogenic peptides should be much smaller. Next, we explored the concentrationdependent amyloid aggregation within the framework of LLPS according to the determined
binodal and spinodal concentrations.
Concentration-dependent amyloid aggregation
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Figure 3-4. The ensemble-averaged fraction of peptides in different components. (A) The
ensemble-averaged fraction of peptides forming fibrils as a function of time at different
total peptide concentrations. (B) The half-time t0.5 as the function of the total peptide
concentration . (C) A snapshot demonstrates the co-existence of different components in
the system, where peptides in LDLP (orange), fibrils (green), and HDLP (purple) are
shown in stick representation. (D) The ensemble-averaged fraction of peptides in different
components, including LDLP, HDLP, and the fibrils and non-fibril aggregates in HDLP,
as the function of time at concentrations  = 20.8, 41, and 125 mM.

We systemically studied the aggregation of amyloidogenic CG peptides over a wide
range of peptide concentrations (Methods). Averaged over 100 independent simulations,
the fraction of peptides forming fibrils – defined as parallel in-register β-sheets with at least
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four strands – was calculated as a function of simulation time at each concentration (Fig.
3-4A). Below the binodal point BL~10.4 mM, we were not able to observe the formation
of fibrils during the courses of all independent simulations. Therefore, BL might
correspond to the critical aggregation concentration as observed in experiments.86 In
between the binodal and spinodal points BL<  < SL, a strong concentration-dependence
in aggregation kinetics was observed. For example, the fibrillization did not saturate within
the simulation time at  = 16.6 mM, but the saturation of fibrillization was observed at a
slightly higher concentration of 20.8 mM. The fibrillization kinetics followed the
characteristic sigmoidal curve as observed experimentally.11 Above the spinodal point SL
~ 25.0 mM, the saturation of fibrillization was observed at all concentrations in the
simulations. The aggregation half-time, t0.5, defined as the time point forming half of the
saturated fibrils, decreased with increasing peptide concentrations, but the dependence on
concentrations was weak at high concentrations (Fig. 3-4B).
Using a threshold aggregate size of 7 (Fig. 3-1C), we monitored the ensembleaveraged time evolution of low- and high-density phases. Fibrils, high density by definition,
corresponded to the solid-like phase, and thus, we separated the high-density phase into
fibrils and non-fibril HDLP (Fig. 3-4C,D). At  = 20.8 mM in between binodal and
spinodal concentrations, the initial dominant species were LDLP including monomers and
small unstable oligomers. The emergence and growth of fibrils correlated with the decrease
of the LDLP, while the fraction of high-density non-fibril aggregates was small and mostly
remained steady. The observed fibrillization kinetics is consistent with the traditional
nucleation and elongation mechanisms, where rare formation of fibril seeds or nucleus is
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followed by elongation via monomer addition. Above the spinodal concentration (e.g.,  =
41 and 125 mM > SL in Fig. 3-4D), non-fibril HDLP aggregates were the dominant species
initially. For example, within 0.15 μs of simulations up to ~90% peptides were rapidly
partitioned into HDLP at  = 125 mM and ~60% at  = 41 mM (right panel, Fig. 3-4D).
The emergence and initial growth of fibrils were accompanied by the loss of non-fibril
aggregates, while the overall fractions of peptides in LDLP and HDLP were approximately
constant – e.g., simulations before ~1.5 μs at  = 41 mM and ~1 μs at  = 125 mM. These
observations suggested that above the spinodal point fibrils were nucleated from the stable
HDLP condensates. The continued fibril growth afterwards was also dominated by
peptides in the non-fibril aggregates, as shown by the strong anti-correlation between
fractions of peptides in fibrils and non-fibril aggregates before the depletion of the latter
component. Next, we examined individual simulation trajectories below and above the
spinodal concentration to assess the aggregation dynamics and pathways.
Amyloid aggregation below the spinodal concentration
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Figure 3-5. Peptide aggregation at 16.6 mM. (A) Time course of the fraction of peptide in
fibrils for three independent trajectories at the peptide concentration of 16.6 mM. (B) The
fraction of peptides in the largest aggregate and fibrils are shown as a function of time for
trajectory 1 in panel A. (C) Snapshots along the trajectory 1 at different times, where the
peptides in monomers (orange), HDLP (purple), and fibrils (green) are shown in stick
representation.
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At the peptide concentration of 16.6 mM approximately the mid-point between BL
and SL, the ensemble averaged fraction of peptides forming fibrils was only ~0.2 at the
end of 30 μs of simulations (Fig. 3-4A). Examination of individual independent simulations
suggested a high heterogeneity in fibrillization kinetics – only 18 out of 100 runs formed
large fibrils within 30 μs of simulations (e.g., three representative trajectories in Fig. 3-5A).
For one of the simulations in Fig. 3-5A, we also plotted the size of the largest aggregate as
a function of time (Fig. 3-5B) and showed snapshots along the trajectory (Fig. 3-5C). Large
fluctuations of the largest aggregate size before the formation of stable fibrils at ~11.5 μs
(i.e., the HDLP) corresponded to frequent association and dissociation of peptides,
consistent with the metastable nature of the system at concentrations between binodal and
spinodal points according to the Flory-Huggins polymer solution theory. The observed
high dynamics including dissolving and reforming (Fig. 3-5B) is consistent with recent
experimental characterization of Aβ oligomers.24 Out of these dynamically formed
aggregates, fibril seeds occasionally formed and disappeared via nucleated conformational
conversion (e.g., t ~ 2.01, 4.5, 8.9 μs in Fig. 3-5B). Stochastically (e.g., t ~ 11.5 μs in Fig.
3-5C), the seeds grew into large fibrils via monomer addition and/or secondary nucleation
(e.g., the formation of another layer of protofibril at 13.5 μs in Fig. 3-5C) by binding of
peptides in LDLP. Therefore, at concentrations below the spinodal concentration, the CG
peptides indeed followed the traditional nucleation and elongation of amyloid fibrillization.
Amyloid aggregation above the spinodal concentration
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Figure 3-6. Peptide aggregation above spinodal concentration. (A) The fraction of peptides
in different components including LDLP and HDLP, as well as fibrils and non-fibril
aggregates in HDLP as a function of time. (B) Snapshots at different times, where the
peptides in monomers (orange), HDLP (purple), and fibrils (green) are shown in stick
representation.
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At the relatively high concentration of 125 mM > SL, variations in terms of
aggregation kinetics among individual simulations were small. For example, the time
course of peptide fractions in various phases for an arbitrarily selected trajectory (Fig. 36A) was similar to the ensemble averages (Fig. 3-4D). As shown by the snapshots in Fig.
3-6B, the peptides first rapidly self-assembled into small HDLP oligomers within ~0.15 μs
of simulations, some of which could interact with each other and grew into larger
aggregates (e.g., at ~0.3 μs in Fig. 3-6B). These non-fibril aggregates were fluidic with
composite peptides conformationally dynamic and diffusive. As a result, multiple fibril
seeds could be nucleated in these condensates (e.g., ~0.45 μs in Fig. 3-6B). The initial
growth of fibrils was dominated by surrounding peptides already in the liquid-like
condensates by either elongation or secondary nucleation (e.g., comparing snapshots at 0.9
and 0.45 us in Fig. 3-6B). Therefore, above the spinodal concentration, the peptides
underwent LLPS first by forming stable non-fibril aggregates with varying sizes, out of
which the nucleated conformational conversion to fibril seeds took place. Before the
depletion of peptides in the condensates, the growth of fibrils was governed by the high
concentration of peptides in proximity within the HDLP.
The potential of mean force of LLPS and fibrillization
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Figure 3-7. Contour plot of the two-dimensional potential mean force (2D PMF) is
presented on the left as a function of the aggregate size (Nagg) and corresponding fraction
of peptides forming fibrils (Qfibril) at peptide concentrations of (A) 20.8 mM, (B) 41 mM,
and (C) 125 mM. Representative snapshots corresponding to denoted basins in the 2D PMF
are shown on the right correspondingly.
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To further characterize the phase separation and amyloid aggregation processes of
peptides at concentrations below and above SL (=20.8, 41, 125 mM as in Fig. 3-4D), we
also computed the two dimensional potential of mean force (2D PMF, or the effective free
energy), -kBTlnP(Nagg, Qfibril), where P(Nagg, Qfibril) corresponded to the probability of
finding peptides in an aggregate with the size Nagg and having a fraction Qfibril of peptides
forming fibrils. (Fig. 3-7). To ensure sufficient sampling, the analysis was done for 100
independent simulations. We also included all simulation trajectories starting from time
zero in order to capture the dynamics of initial phase separation. Despite the shared basin
near ~ [100, 1] denoting the formation of large fibrils (e.g., stable fibrils in Fig. 3-5C and
3-6B), distinct self-assembly pathways were observed under different concentrations. At
the concentration ~125 mM that was significantly above SL, the most probable
fibrillization pathway corresponded to the initial formation of large non-fibril aggregates
( basin ~[90, 0] and a representative snapshot in Fig. 3-7C) from isolated monomers,
followed by the nucleation and growth of fibrils with weak barriers by conformational
conversion of proximal peptides (e.g., β basin and the corresponding snapshot in Fig. 37C). When the peptide concentration ~41 mM was just above the SL, multi-sized HDLP
oligomers comprised of up to ~75 peptides were initially formed (e.g., basin a and a
representative snapshot in Fig. 3-7B). Since fibril seeds could be nucleated out of oligomers
with multiple sizes (basin b and a corresponding snapshot in Fig. 3-7B), more heterogenous
fibrillization pathways were observed. At the concentration ~20.8 mM just below SL,
peptides only formed meta-stable HDLP oligomers with small sizes (basin 1 and
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corresponding snapshot in Fig. 3-7A), and the fibril seeds were nucleated out of these small
aggregates with a high energy barrier (basin 2 and corresponding snapshot in Fig. 3-7A).
Amyloid aggregation under the lens of LLPS
Our CG simulations demonstrated that the nucleation of HDLP condensates or
oligomers (Fig. 3-1C) and the nucleation of fibril seeds (Fig. 3-7) were two different
processes. The first process was analogous to the formation of droplets in the first-order
gas/liquid phase transition. However, these oligomers did not immediately convert into
fibrils, because conformational conversion of peptides was required to form fibrils and the
corresponding conformation in fibrils was a high energy state of an isolated peptide.
Peptides in these oligomers can cross the energy barrier to sample the fibrillization-prone
β-state and form small transient β-sheets. Out of these oligomers with variable sizes and
life-times (e.g., from meta-stable at concentrations between BL and SL to stable above
SL), the nucleation of fibril seeds only took place after forming β-sheets with extensive
backbone hydrogen bonds to overcome the energy loss associated with the conformational
change to the fibrillization-prone state. In other words, the free-energy barriers associated
these two nucleation processes were along two orthogonal reaction coordinates as shown
in the 2D PMF in Fig. 3-7.
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Figure 3-8. (A) Schematic diagram of the amyloid aggregation mechanism through LLPS
at high concentrations. (B) Schematic diagram of the corresponding amyloid aggregation
kinetic curves. The dot-dashed blue line corresponds to the limiting aggregation in an ideal
homogeneous solution with the concentration of ϕ BH, i.e., in pure HDLP. The dot-dashed
green line denotes the contribution of fibrils formed from the HDLP with the peptide
fraction fH. The solid line is the actual aggregation kinetics for the system that underwent
LLPS with peptides partitioned into coexisting LDLP and HDLP above the spinodal point.
With fH close to 1 at high concentrations, the aggregation is dominated by peptides in
HDLP, and the corresponding kinetics approaches the limiting case in pure HDLP. (C) The
aggregation half-time t0.5 as a function of the inverse of the total concentration ϕ–1, from
CG simulations.
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Figure 3-9. ThT aggregation kinetics study of IAPP (5-125 μM) at 37 °C. At each
concentration, the averaging was done over three independent measurements with standard
devotions shown as error bars.

The fibrillization process of the CG peptides below the spinodal concentration SL
resembled classical nucleation and elongation of fibrils, but deviated significantly at high
concentrations above the spinodal point due to rapid phase separation (Fig. 3-8A).
According to the Flory-Huggins theory, the change of total peptide concentration only
results in the change of peptide partition between the LDLP at the centration of BL and the
HDLP at BH – i.e., the fraction of HDLP is approximately fHDLP = 1- BL/. Under the high
concentration limit  >> BL, fHDLP approaches 1 and the fibrillization half-time t0.5 should
approach the limiting t0.5,HDLP for the fibrillization in pure HDLP at the concentration of
BH (Fig. 3-8B),
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𝑡0.5 ≈ 𝑡0.5,𝐻𝐷𝐿𝑃 +

(0.5−0.5𝑓𝐻𝐷𝐿𝑃 )
𝑘𝑒

0.5BL

≈  𝑡0.5,𝐻𝐷𝐿𝑃 + 𝑘

𝑒,𝐻𝐷𝐿𝑃 

,

(1)

where ke is the elongation rate at the midpoint and also approaches the limiting value ke,HDLP
in pure HDLP. We plotted t0.5 as the function of the inverse of the peptide concentration 1

from simulations (Fig. 3-8C) and ThT experiments of IAPP aggregation (Fig. 3-3 and 3-

8D). Despite the different aggregation behavior between CG peptides in simulations and
IAPP in experiments at lower concentrations likely due to different aggregation
mechanisms (e.g., differences in the size of critical nucleus, the dominance of the primary,
secondary nucleation and fragmentation), the similar linear dependence at high
concentrations between CG simulations and experiments as predicted in Eq. 1 confirmed
the saturation of aggregation at high concentrations due to LLPS. In contrast, aggregation
kinetics models without considering LLPS usually predict a power-law scaling of the halftime to zero with respect to increasing peptide concentrations.87 Interestingly, global fitting
the experimental aggregation kinetics over a wide range of concentrations with AmyloFit88
with different aggregation models suggested that IAPP likely follow different aggregation
mechanisms at different concentrations (Fig. 3-9).
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Figure 3-10. ThT kinetics assay and TEM imaging of IAPP aggregation. (A) Global fitting
of the normalized aggregation kinetics over the concentration rage of 5–125 μM according
to the secondary nucleation dominant model. (B) The experimental aggregation half-time
t0.5 as a function of the inverse of the total concentration, ϕ–1. (C–G) IAPP aggregates in
diameter after 15 min of incubation. (H, I) Coexistence of spherical IAPP aggregates of
various sizes and protofibrils after 15 min of incubation. (J) IAPP amyloid fibrils after 2 h
of incubation. IAPP concentration: 125 μM. Scale bar: 50 nm.
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To test whether IAPP undergoes LLPS at high concentrations, we performed
transmission electron microscopy (TEM) of IAPP after 15 min of incubation at 37 °C and
for a concentration of 125 µM (Fig. 3-10A-D). Indeed, the formation of large aggregates
with a wide range of diameters up to 50-180 nm has been observed. Spherical shapes are
consistent with the minimization of surface areas of the liquid-like HDLP aggregates.
Moreover, the co-existence of HDLP droplets and protofibrils has also been obtained (Fig.
3-10E-G). Longer incubation times led to the formation of amyloid fibrils as expected (Fig.
3-10H).
Using a similar CG model in Langevin dynamics simulations, Pellarin and Caflisch
observed similar aggregation behaviors at different peptide concentrations.63 Only after
placing amyloid aggregation under the framework of Flory-Huggins phase separation
theory, we were able to provide a unified picture of amyloid aggregation for a wide range
of concentrations. Saric et al. proposed a two-step nucleation mechanisms via dynamically
formed oligomers with an optimal size, known as the critical nucleus.23,84 In our model, the
nucleation of fibril seeds can occur inside HDLP oligomers with a wide range of sizes. At
high concentrations, oligomers can be very large. The conversion of the HDLP oligomers
into fibrils is not all-or-none. Hence, we proposed to use two reaction coordinates – e.g.,
the aggregate size (Nagg) and the fraction of peptides forming fibrils (Qfibril) – to describe
amyloid aggregation dynamics.
The aggregates of our CG peptides in HDLP adopted the shape of micelles or
tubular micelles (e.g., Fig. 3-5,3-6). However, prior works on the phase separation of
block-copolymers have established that the high-density aggregates can have more
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complex morphologies – including micelles, tubes, tubular micelles, lamellae, and
networks – depending on the block-copolymer composition, such as the ratio of
hydrophobic and hydrophilic components89,90. With large sequence variations of different
amyloid peptides, the HDLP might also adopt different morphologies. Further studies are
necessary to uncover the effects of HDLP morphologies on amyloid aggregation.
Conclusion
In summary, we investigated the dynamics of LLPS and amyloid fibrillization of a
model CG peptide over a wide range of concentrations in DMD simulations. By capturing
only fundamental properties of amyloid peptides (e.g., the conformational change between
fibrillization-incompetent and amyloid-prone states, and the distance and angulardependent backbone hydrogen bonding as the driving force), we were able to observe
spontaneous liquid-liquid phase separation and formation of amyloid fibrils in simulations.
Based on the Flory-Huggins theory of polymer solutions, we determined the binodal and
spinodal concentrations, BL and SL, at the low concentration regime for the CG peptide
model (Fig. 3-1). Only at concentrations above BL, fibril formation was observed in
simulations (Fig. 3-4), suggesting that BL might correspond to the critical aggregation
concentration in experiments.86 Fibril seeds were nucleated out of HDLP aggregates or
oligomers with varying sizes and life-times depending on the total peptide concentration –
e.g., small and meta-stable below the spinodal concentration SL, large and stable above
SL (Fig. 3-5,3-6). Our results highlighted the difference between the nucleation of HDLP
aggregates/oligomers and the nucleation of fibril seeds, corresponding to free-energy
barriers along two orthogonal reaction coordinates – the aggregate size Nagg and the
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fraction of fibrils Qfibril (Fig. 3-7). With the partition of peptides into two co-existing
phases with fixed local concentrations (i.e., BL and BH, Fig. 3-1A) according to the FloryHuggins theory, LLPS implies the saturation of aggregation kinetics with increasing
concentrations above SL to the limiting case of aggregation in pure HDLP. Our simulations
supplemented with ThT and TEM experiments confirmed the prediction (Fig. 3-8&3-10).
Hence, our study, for the first time, systematically examined amyloid aggregation within
the framework of LLPS and offered a unified picture of amyloid aggregation for a wide
range of concentrations pertinent to the etiology of amyloid diseases including systemic
amyloidosis, neurological disorders and type 2 diabetes, where the concentration of
amyloidogenic peptides can span and fluctuate over some nine orders of magnitude, from
pico-molars to micro-molars and milli-molars in the blood, cerebrospinal fluid, the brain
and the pancreas.91–94 Understanding the energetics and phase transitions of amyloid
aggregation may, in addition, facilitate the engineering of amyloid-based novel functional
materials.83
Materials and Methods
Discrete Molecular Dynamics (DMD) simulations
DMD is one type of molecular dynamics algorithms where conventional continuous
interaction potentials are replaced by optimized step functions.95,96 As a result, any atom
moves with constant velocity until an interatomic interaction potential step is encountered,
i.e., a collision event. New velocities of two colliding atoms are determined by
conservation laws of energy, linear and angular momenta. The dynamics of the molecular
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system is obtained by iteratively predicting and updating the collision events. Optimization
of the DMD algorithm can be found elsewhere65.
Coarse-grained amyloid peptide model
The CG peptide model was previously developed for DMD simulations to study
the effects of chiral silica nanoribbon on amyloid aggregations40. Briefly, each CG peptide
was composed by 11 beads (insert in Fig. 3-1B), including two sets of hydrogen bond donor
(red) and acceptor (blue) connected to the backbone bead (grey), two hydrophobic
sidechain beads (green), and three hydrophilic beads (yellow). The angular and distancedependent hydrogen bonds could be formed between donors and acceptors attached to the
backbone beads via a reaction-like algorithm.66 Motivated by a previous CG peptide
model,97–99 we allowed the peptide to adopt two conformations: fibrillization-prone (β) and
fibrillization-incompetent (π) states (Fig. 3-1B). In the β-state, the dihedral angle defined
by the two sidechain beads and the correspondingly attached backbone beads with
minimum free energy was ~15°, and thus, both donors and acceptors in the peptide were
approximately parallel to each other, compatible with a long fibrillar state. On the other
hand, the π-state had the dihedral angle ~90° and was incompatible with the linear fibril.
In this study, the π-state of an isolated peptide was more favorable than the β-state with a
lower free energy, e.g., ΔEπβ ~1.0 kBT for the amyloidogenic peptide model. We adopted
an HP-like interaction potential model68 for non-bonded interactions–an attractive
potential, ~2 kBT, was assigned among hydrophobic beads, and a hard-core only
interaction potential was assigned among hydrophilic beads and between hydrophobic and
hydrophilic atoms. The net energy gain for a hydrogen bond was ~3.5 kBT. For the non-
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amyloidogenic model, the peptide could only occupy the fibrillization-incompetent π state
by assigning ΔEπβ >> kBT and ΔEπ >> kBT.
Coarse-grained simulation setup
We systematically investigated the amyloid aggregation and phase separation (or
oligomerization) by utilizing the amyloidogenic and non-amyloidogenic models. To
determine the spinodal and binodal point, 13 non-amyloidogenic systems were setup with
increasing concentration from 2.6, 5.2, 10.4, 15.0, 20.8, 25.0, 30.0, 35.0, 41.0, 83.0, 125,
166, to 206 mM, corresponding to 100 peptides randomly placed in simulation box with
4003 Å, 3173 Å, 2523 Å, 2233 Å, 2003 Å, 1883 Å, 1773 Å, 1683 Å, 1593 Å, 1263 Å,
1103 Å, 1003 Å, and 933 Å, respectively. Similarly, 13 amyloidogenic systems with
increasing peptide concentration were built up to capture the concentration dependent
amyloid aggregation using the amyloidogenic model. For each molecular system, 100
independent simulations with different initial inter-molecular distances and orientations.
Analysis methods
For the analysis of the CG aggregation simulations, the number of peptides in each
fibril was monitored. A peptide belonged to a β-sheet only if it was in the β-conformation
and was stabilized by at least two interpeptide hydrogen bonds. A fibril is comprised of βsheets with at least 4 peptides. As for analyzing the number of peptide in each aggregate,
a single-linkage clustering analysis of snapshot structures along the simulation trajectories
was performed: two peptides were in contact if making at least one intermolecular contact
and a peptide belonged to an aggregate if it was in contact with any of the member peptides.
The interatomic distance cutoff of 0.75 nm.
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The two-dimensional potential mean force (2D PMF) was computed according to
PMF = - kBT ln P(Nagg, Qfibril), where P(Nagg, Qfibril) denoted the probability of finding
peptides in an aggregate with the size Nagg and having a fraction Qfibril of peptides forming
fibrils. Briefly, for each snapshot, we performed the single-linkage clustering analysis. For
each of the aggregate, its Qfibril value was obtained by computing the number of composite
peptides forming fibrils – i.e., stable β-sheets with at least 4 peptides. By analyzing all
independent simulations starting form time zero, the mass-weighted histogram was
computed.
ThT experiment
Lyophilized

human

islet

amyloid

polypeptide

IAPP

(37

residues,

KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY, MW=3904.5 Da; purity: 95%
by HPLC) was purchased from AnaSpec. The peptide monomers were pre-treated with
hexafluoroisopropanol (HFIP) to break down potential aggregates present, dissolved in 1.0%
NH4OH, and diluted using phosphate buffer saline (Sigma) (pH 7.4, the isoelectric point
of 8.9 for IAPP) for preparing the range of monomeric concentrations.100 No further pH
adjustment was applied, in order to avoid alterations to peptide aggregation introduced by
salts. Thioflavin T (ThT) fluorescence dye was used to indicate the amyloid fibril formation.
The ThT kinetics assay was conducted for the selected range of monomeric IAPP solutions
(5 μM-125 μM) along with twice the concentration of ThT dye in a 96-well plate (Costar
black/clear bottom), and changes in ThT fluorescence were recorded every 10 min at 37 °C
till the full saturation phase of the peptide peptide was reached. Lower peptide
concentrations than 5 μM would challenge the ThT assay in resolving peptide aggregation..
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The assay was done in triplicate and the measurements were carried out using a
PerkinElmer EnSight HH33400 plate reader through the bottom of the plate, with an
excitation filter of 440 nm and an emission filter of 485 nm.
Transmission electron microscopy (TEM) experiment
IAPP solution (125 μM) was prepared in PBS as described above. IAPP was
incubated at 37 °C up to 2 h and 5 µL of the samples were pipetted onto 15 s glowdischarged 400 mesh copper grids (Formvar film, ProSciTech) for 60 s of adsorption.
Excess samples were drawn off by filter paper and the grids were washed with 5 μL of
Milli-Q water, with excess drawn off. The grids were then negatively stained with 5 μL of
1% uranyl acetate for 30 s with excess stain drawn off and air-dried. The samples were
characterized on a Hitachi HT7700 transmission electron microscope operated at a voltage
of 80 kV.
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CHAPTER FOUR
EFFECTS OF PROTEIN CORONA ON ISLET AMYLOID POLYPEPTIDE
AMYLOID AGGREGATION, FIBRIL REMODELING, AND CYTOTOXICITY
Introduction
Human islet amyloid polypeptide (IAPP) is a 37-residue peptide hormone that, along
with insulin, plays an essential role in glycemic control.101 IAPP is stored in soluble forms
at millimolar concentrations in the islets of Langerhans before being released to the
bloodstream. Accumulating evidence suggests that amyloid aggregation of IAPP is related
to pancreatic β-cell death in type-2 diabetes (T2D), a debilitating disease impairing 368
million people worldwide.102 In vitro studies have revealed that IAPP at micromolar
concentrations can readily fibrillate into amyloids within hours, indicating that pancreatic
β-cells endogenously inhibit IAPP aggregation.103
Earlier studies ascribed IAPP amyloids as the toxic species,104,105 while more recent
studies pointed to IAPP oligomers as the causative toxic agent for β-cell loss.106 The
ambiguities surrounding IAPP toxicity largely stem from the difficulty in isolating IAPP
monomers from oligomers, protofibrils and amyloids due to the rapid fibrillation kinetics
of the peptide, as well as the complex intra- and extra-cellular environments of the IAPP
species where peptides, proteins, lipids and fatty acids occur in abundance.106 In
consideration of the changing conformation and hydrophobicity of IAPP during its
fibrillation process, it is reasonable to postulate that the molecular ligands encountered by
IAPP from cradle to grave may exert effects on the physical and biological identities of the
IAPP species.
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Surprisingly, little is known concerning IAPP-protein interactions and their biological
and pathological implications. In this study we examined the binding of both fresh IAPP
and mature IAPP amyloids with two model proteins, lysozyme (Lys) and alpha lactalbumin
(aLac). Lys and aLac are homologous proteins with similar tertiary structures (14 kDa,
41% helical and 9% beta sheets) while carrying opposite net charges. Lys is an enzyme
commonly found in saliva and tears responsible for hydrolyzing peptidoglycans in bacterial
cell wall while aLac from mammal milk regulates lactose biosynthesis. Both Lys107 and
aLac108 can also be found in circulation. We used thioflavin T (ThT), Circular Dichroism
(CD), and high-resolution transmission electron microscopy (TEM) to assess IAPP
aggregation and fibril remodeling, and performed a viability assay with human umbilical
vein endothelial cells (HUVECs) to evaluate the toxicities of fresh IAPP and IAPP
amyloids in the presence of the model proteins. Specifically, co-incubated with IAPP
peptides at a 1:1 molar ratio Lys inhibited IAPP aggregation with no visible fibril formation
while aLac induced amorphous aggregation containing significant beta-sheet contents.
TEM imaging revealed that both aLac and Lys bound mature fibrils and binding of aLac
led to fibril softening. Surprisingly, the cell viability study indicated that Lys enhanced but
aLac reduced the cytotoxicity of IAPP peptides, whereas binding of either Lys or aLac with
mature IAPP fibrils mitigated the fibril toxicity.
To gain a molecular insight into the binding of homologous Lys and aLac proteins with
both soluble IAPPs and insoluble amyloid fibrils and to understand the corresponding
differential effects on IAPP-mediate cytotoxicity, we performed discrete molecular
dynamics (DMD) simulations to examine the structure and dynamics of a selected few of
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relevant molecular systems. DMD has been successfully applied in our previous studies
of IAPP aggregation inhibition by polyphenol,109 graphene oxide,110 and dendritic
polymers,111 and offered molecular details in this study especially concerning inhibition of
IAPP fibril formation and elevation of IAPP toxicity in the presence of Lys. Both Lys and
aLac were found to bind positively charged IAPP monomers in silico. Simulations of
multiple proteins and peptides at a 1:1 molar ratio showed that one Lys protein could bind
multiple IAPP peptides and the increased net charge of the IAPP-Lys clusters prevented
further peptide association. Therefore, Lys binding stabilized IAPP oligomers, known to
be more toxic than the fibrils, and resulted in increased toxicity of IAPP. In contrast, aLac
co-aggregated with IAPPs by forming large protein-peptide complexes through
electrostatic attraction, yielding the experimentally observed amorphous aggregates with
less toxicity compared to IAPP alone. Our simulations also showed that both Lys and aLac
could bind the fibrils, which likely reduced cell exposure to the fibrils and hence mitigated
cytotoxicity. To account for the higher protein to IAPP ratio in physiological conditions,
we performed additional DMD simulations with an 8:1 protein to IAPP molar ratio.
Crowded with proteins (either aLac, Lys, or their mixture), the IAPP peptides tended to
bind one protein, which minimized the formation of both toxic oligomers and amorphous
aggregates. Together, our combined in silico and in vitro study has revealed the contrasting
effects of proteins on IAPP amyloid aggregation, fibril remodeling and cytotoxicity
depending on the physicochemical properties as well as the relative concentrations between
the proteins and IAPP peptides, pointing to a natural defense mechanism of biological
systems in mitigating the toxicities elicited by amyloidogenic species.
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Results and discussion
Biophysical characterizations of protein binding on IAPP aggregation and fibril
remodelling
Zeta potentials
IAPP (IEP: 8.9) assumed a zeta potential of +36.8 mV at neutral pH, while Lys
(IEP: 9.1) and aLac (IEP: 4.2) displayed zeta potentials of +12.1 mV and -14.6 mV,
respectively. Based on their primary sequences, the corresponding net charges of
monomeric IAPP, Lys and aLac are +2e, +7e and -7e. The observed higher zeta potential
of IAPP with a smaller net charge was possibly due to their rapid formation of oligomers
and protofibrils in solutions.
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Figure 4-1. IAPP fibrillation inhibition and amyloid remodelling by lysozyme (Lys) and
α-lactalbumin (aLac). (A) Thioflavin T (ThT) fluorescence assay shows IAPP fibrillation
in the presence of Lys and aLac over 14 h. (B) TEM images of IAPP fibrillation inhibition
(upper panel) and IAPP amyloid remodelling (lower panel) mediated by Lys and aLac at a
o

1:1 molar ratio after incubation in Milli-Q water for 24 h at 25 C. Formation of a visible
IAPP-aLac precipitate (upper middle panel, inset) and soft aLac-amyloids (lower middle
panel, white circles) are shown. Scale bars: 200 nm. (C) Circular dichroism (CD) shows
the β-sheet content of IAPP in the presence of aLac and Lys, in addition to the aLac and
Lys controls, over 48 h. (D, E) Analysis of IAPP amyloid fibril diameter (D) and persistence
length (E) in the presence or absence of Lys and aLac. IAPP concentration = 25 μM for all
experiments. **** p < 0.0001 (unpaired t-test, n = 100).
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ThT and CD assay quantifications of IAPP fibrillation inhibition by proteins
IAPP, aLac and Lys were incubated with the amyloid-sensitive ThT dye to quantify
the rate and kinetics of IAPP fibrillation over 14 h (Fig. 4-1A), in addition to visualising
change in protein secondary structure up to 48 h through CD spectroscopy (Fig. 4-1C). It
was demonstrated that IAPP alone remained in the energetically unfavourable nucleation,
or lag, phase up to 5 h, before entering the elongation phase, and by 14 h was within the
saturation phase (Fig. 4-1A). This is in turn was complemented by an increase of IAPP βsheet content from 35.4% at 0 h to 50.7% after 48 h (Fig. 4-1C), indicative of the increasing
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prevalence of β-sheet rich amyloid species.
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Figure 4-2. Circular dichroism analysis of aLac and Lys controls after 48 h. The percentage
of β-sheet content within the secondary structures of aLac and Lys alone (UT) did not show
any significant change when incubated at a 1:1 molar ratio with IAPP (M).
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The secondary structure of IAPP mixed with aLac showed an analogous increase in
β-sheets to the IAPP control after 48 h (Fig. 4-1C), which was not complemented in aLac
(Fig. 4-2). Comparative to IAPP alone, however, IAPP-aLac did not show evidence of
sigmoidal fibrillation, and the increase in ThT fluorescence followed a more linear trend
(Fig. 4-1A). IAPP-aLac also attained the largest increase in ThT fluorescence overall,
indicating a promotional effect of aLac on IAPP aggregation. The non-sigmoidal
fibrillation trend, however, was consistent in all experiments; the combined intensity and
kinetics observations therefore suggest formation of unstructured, amorphous IAPP
aggregates in the presence of aLac. Conversely, complete inhibition of IAPP was observed
in the presence of Lys over the 14 h sampling period for ThT (Fig. 4-1A); concordantly,
no increase in the percentage of IAPP β-sheet structure in IAPP:Lys was seen after 48 h
(Fig. 4-1C). Each protein therefore mediated opposing effects on IAPP fibrillation, both in
terms of β-sheet content and kinetic behaviour.
High-resolution TEM imaging of IAPP fibrillation inhibition and remodelling by proteins
TEM imaging was perfromed to complement ThT analysis through visualization of
the aggregation products (Fig. 4-1B, upper panel), and also to examine IAPP amyloid
remodelling mediated by aLac or Lys (Fig. 4-1B, lower panel). The TEM images were
further analyzed using statistical software FiberApp112 to determine the morphological and
mesoscopic changes of mature IAPP amyloid fibrils incubated with aLac or Lys, including
fibril diameter (Fig. 4-1D) and persistence length (fibril stiffness) (Fig. 4-1E).
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By 24 h incubation of IAPP alone, both long fibrils and smaller aggregates (also
known as protofibrils) appeared (Fig. 4-1B, upper panel). Neither of these structures was
observed in the presence of aLac or Lys, however. Specifically, IAPP fibrillation was
completely inhibited by Lys, with only a few small, worm-like structures present after 24
h. Electrostatic repulsion between the positively charged IAPP and Lys likely
compromised IAPP-IAPP interactions. In comparison, the IAPP-aLac mixture was mainly
present as large amorphous aggregates after 24 h, which was also observed as off-white
precipitates in solution (Fig. 4-1B upper panel, inset). Based on the ThT assay (Fig. 4-1A),
the amorphous aggregates contained significant beta-sheet structures. Considering the
opposing charges of IAPP and aLac, it is likely that electrostatic attraction with aLac
strongly perturbed IAPP self-assembly into fibrils, while favoured formation of amorphous
structures.
Alternatively, formation of non-fibrillar species has been observed in both IAPP and
Aβ amyloidogenesis when monomers interact with hydrophobic surfaces113,114. This
suggests that IAPP-aLac could act as a seed, promoting contact between monomeric or
low-order oligomeric IAPP species, yet directing aggregation off-pathway.
Mature IAPP amyloids formed by IAPP alone after 30-60 days of incubation were
long and semi-flexible (Fig. 4-1B, lower panel). The presence of some shorter species is
attributed to the cross-linking and subsequent gelation of mature IAPP amyloids24, which
can result in some fibril breakage during pipetting from the stock. Statistical analysis of
these fibrils revealed an average diameter of ~ 8.9 nm (Fig. 4-1D) and an average
persistence length of ~ 2,100 nm (Fig. 4-1E). When incubated with aLac and Lys, IAPP
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amyloids underwent remodelling, as indicated by changes in fibril diameter and
morphology compared to IAPP amyloids alone (Fig. 4-1B, lower panels). Both aLac and
Lys interacted with the fibrils, mediating a significant shift in average fibril diameter (Fig.
4-1D) from approximately 8.9 nm (IAPP amyloid control) to 12.1 nm (aLac) and 14.5 nm
(Lys), correspondingly. Interestingly, interaction with aLac halved the persistence length
of amyloid fibrils (Fig. 4-1E) indicating significant fibril softening, while no difference
was seen in IAPP stiffness with Lys binding.
The endogenous inhibition of Aβ(1-40) fibrillation mediated by several nonchaperone proteins, including aLac and Lys, has been previously reported.1155 It was shown
that fibrillation of the negatively charged Aβ was inhibited by aLac and Lys at a ~ 1:1
molar ratio, yet both proteins were unable to promote disaggregation of pre-formed Aβ
fibrils. In the case of IAPP, although both aLac and Lys inhibited the fibrillation, aLac
promoted the formation of large amorphous aggregates with significant beta-sheet content
while Lys prevented any formation of aggregates that can be detected by either ThT and
TEM imaging. The differential impact on IAPP amyloid aggregation and remodelling of
IAPP amyloids by aLac and Lys in our study suggests that both electrostatic and
hydrophobic interactions between proteins and IAPP can alter the intrinsic properties of
IAPP amyloids; as such, it is likely that IAPP amyloids can facilitate interactions with a
multitude of components in the environmental milieu. Formation of a ‘protein corona’116,117
on IAPP amyloids in vivo is likely to have a significant effect on IAPP amyloid toxicity,
and merits further investigation.
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Effects of protein binding on the viabilities of fresh IAPP and IAPP amyloids

A

B

Figure 4-3. Viability of HUVECs exposed to 25 μM IAPP and amyloids in the presence of
α-lactalbumin (aLac) and lysozyme (Lys) after 24 h. (A) Bright-field images reveal
extensive cell death in the presence of IAPP, and some loss of cells with IAPP amyloids.
(B) The calcein-AM viability assay demonstrates high toxicity of IAPP (left) and, to a
lesser extent, IAPP amyloids (right). Significant mitigation of toxicity in amyloids was
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observed when pre-treated with aLac and Lys. Scale = 25 μm; * p < 0.05 (one-way ANOVA,
n = 3).
Bright-field imaging (Fig. 4-3A) showed healthy control HUVECs as highly confluent and
endothelial-like in morphology. Microscopic examination was additionally complemented
by the calcein-AM assay (Fig. 4-3B) for quantitative measurement of cell viability against
an untreated control. Large-scale cell damage and death was observed with IAPP,
regardless of the presence or absence of aLac or Lys (Fig. 4-3A, middle row). Viability
data (Fig. 4-3B, left panel) for IAPP (22% viability), IAPP-aLac (29%) and IAPP-Lys (7%)
further demonstrated that aLac and Lys, though capable of inhibiting IAPP fibrillation, had
no mitigating effect on the peptide toxicity. In fact, IAPP-Lys mixture showed notably
higher toxicity in HUVECs than IAPP alone, suggesting that Lys binding might stabilize a
highly toxic species of IAPP with the low molecular weight species (Fig. 4-1). The reduced
toxicity of IAPP-aLac mixture was likely due to the fact that the formed amorphous
aggregates were very large and precipitated (Fig. 4-1B, IAPP-aLac inset), reducing their
exposure and subsequent toxic effects to cells.
Interestingly, different phenomena were observed when aLac and Lys were
incubated with IAPP amyloids. Large deposits of mature amyloid aggregates were seen
with each condition (Fig. 4-3A, lower row); however, extensive cell destruction, as
visualized with IAPP, was not present. In amyloid-aLac and amyloid-Lys, healthy cells
were observed. This effect is corroborated by the viability data (Fig. 4-3B, right panel); the
relatively lower level of toxicity mediated by IAPP amyloids (47% viability) was
significantly reduced in the presence of both aLac (81% viability) and Lys (85% viability).
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Therefore, our results suggest that the formation of aLac or Lys ‘corona’ on the amyloid
fibril surface likely screened the amyloid-cell interactions and thus reduced the amyloid
fibril-induced cytotoxicity.
In a previous study, we explored the complex nature of IAPP fibrillation species
and their associated toxicities.1188 We demonstrated that fibrillating, stabilized oligomeric
and mature amyloid IAPP species were toxic to different extents to pancreatic beta cells in
vitro. This study supports this narrative with a different cell line and hence a different in
vitro IAPP environment, and additionally provides new insight. To better understand the
differential effects of aLac and Lys binding on IAPP aggregation, fibril remodelling and
toxicity, we next performed atomistic DMD simulations to study the binding of aLac or
Lys with both soluble IAPP monomers and amyloid fibrils.
DMD simulations of protein binding with soluble IAPP and IAPP fibrils
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Figure 4-4. Binding of an IAPP monomer with aLac and Lys. (A) Radius of gyration of
IAPP as a function of time. (B) β-sheets of IAPP as a function of time.
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Figure 4-5. Binding of an IAPP monomer with aLac and Lys. (A) Binding frequencies of
IAPP monomers with either aLac or Lys during the course of simulations. (B) Binding
probability of each IAPP residue with either aLac or Lys was derived from the IAPPprotein complexes in DMD simulations. Similarly, the binding probabilities of residues in
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aLac (C) and Lys (D) with IAPP were also computed. The residues with peaks values were
highlighted, where the residue indices were re-numbered from 1 in each corresponding
sequence. (E) Typical snapshot structures of IAPP-protein complexes. The molecular
surfaces of both aLac and Lys were shown to highlight their binding with IAPP (colored
grey in cartoon representation), where each protein residue was colored from blue (low) to
red (high) according to its binding probability to IAPP as in panels C &D. Two different
views were given to illustrate multiple IAPP-binding sites on the protein surfaces, and
corresponding electrostatic potential surfaces (estimated with PyMol) were shown in the
inset.

We first performed DMD simulations of IAPP monomers binding with either aLac
or Lys. For each molecular system here and later in the study, 20 independent simulations
were performed at 300 K with different initial inter-molecular distances and orientations.
Each simulation lasted 50 ns so that an accumulative 1 μs of total DMD simulations was
achieved for each molecular system. Despite the intrinsically high conformational
flexibility of IAPP, structural analysis of the peptide along simulation trajectories (e.g.,
radius of gyration and secondary structure contents in Fig. 4-4) suggested that an
equilibrium or “steady-state” in terms of conformational dynamics was achieved in
simulation. We found that IAPP could bind to both proteins, with aLac having a higher
binding frequency to IAPP than Lys (Fig. 4-5A). The stronger binding of aLac with IAPP
is mainly due to their opposite net charges. Based on the bound complex structures, we
computed the binding probability of each IAPP residue with the proteins (Fig. 4-5B). The
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peptide residues had an overall higher binding probability with aLac than with Lys. As
highlighted in Fig. 3-5B, the residues with peak binding values along the peptide sequence
were mostly hydrophobic, with the positively charged R11 also displaying strong binding
to aLac. Similarly, we computed the binding probability of the protein residues with IAPP
(aLac in Fig. 4-5C and Lys in Fig. 4-5D). Since Lys and aLac were structural homologs
with ~35% sequence identical (Smith-waterman algorithm119), the residue-wise IAPP
binding profiles for aLac and Lys shared some similarities (e.g., residues around Nterminal, 20, and 30-50 in Fig. 4-5C,D). One major difference was the high peak around
residues 100-110 for aLac that was absent for Lys. The residues of aLac with high IAPPbinding values were mostly hydrophobic (Fig. 4-5C), while the IAPP-binding residues in
Lys were more hydrophilic (Fig. 4-5D). Typical snapshot structures, where the protein
residues were color-coded according to their IAPP-binding frequencies (Fig. 4-5E),
indicated the similarities and differences of peptide binding with aLac and Lys. The Cterminal of IAPP tended to bind to a clef of aLac and Lys (e.g., residues 30-50), while the
N-terminal of IAPP made contact with aLac (i.e., residues 100-110 as in Fig. 4-5C) but not
with Lys. A different viewpoint of the complex structures shows other IAPP-binding sites,
suggesting a relatively non-specific binding of IAPP with either aLac or Lys. Therefore,
our simulations revealed that IAPP-aLac binding was dominated by hydrophobic
interactions while IAPP-Lys binding was mainly driven by polar interactions. We note that
the relative contributions of various IAPP-protein interactions derived from simulations
can be validated experimentally by site-directed mutagenesis of corresponding residues
and subsequent measurements of peptide binding. As our current study is focused on the
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effects of protein binding on IAPP aggregation, these protein-peptide binding interactions
warrant future investigations.

Figure 4-6. Binding of multiple IAPPs with multiple proteins of fixed positions. (A)
Number of unbound IAPP peptides averaged over independent simulations as a function
of simulation time. (B) Histograms of the number of peptides bound to either aLac or Lys
were computed from the last 12.5 ns of corresponding simulations. (C, D) Snapshot
structures of IAPP (cyan) peptides binding with both aLac (orange; C) and Lys (purple; D),
where both peptides and proteins were in cartoon representation.
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To elucidate the binding of multiple IAPP peptides with multiple proteins, we tested
molecular systems with 6 proteins and 6 peptides. Considering the significant
computational cost to simulate such large systems, we allowed peptides free to move while
fixed the coordinates of all proteins. We found that IAPPs rapidly bound to either aLac or
Lys, with only small fractions of unbound IAPP at the end of the simulations (Fig. 4-6A).
To understand how the peptides were bound to proteins, we performed a cluster formation
analysis of snapshot structures along the simulation trajectories: two molecules formed a
cluster if they were in contact (i.e., making at least one inter-molecular contact) and two
molecules belonged to a cluster if both of them were in contact with another molecule. For
simulations of each protein, we used the last 12.5 ns of 20 independent simulations where
the binding was apparently equilibrated (Fig. 4-6A), and computed histograms of the
number of IAPP peptides forming a cluster with a single protein (Fig. 4-6B). While the
probability of finding a single IAPP bound a single protein was the highest for both aLac
and Lys, multiple IAPPs could bind to a single protein with high probabilities (e.g.,
snapshot structures in Fig. 4-6C,D). Therefore, both aLac and Lys could bind IAPP
oligomers.
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Figure 4-7. Binding of two IAPPs with two free proteins. (A) Average number of proteins
belonging to a protein-containing cluster. (B) Histogram of the number of proteins in a
protein-containing cluster. (C, D) Snapshot structures of IAPP (cyan) peptides binding with
aLac (orange; C) and Lys (purple; D), taken from DMD simulations.
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Figure 4-8. Binding of four IAPPs with two free proteins. (A) Average number of proteins
belonging to a protein-containing cluster. (B) Histogram of the number of proteins in a
protein-containing cluster. (C, D) Snapshot structures of IAPP (cyan) peptides binding with
aLac (orange; C) and Lys (purple; D).
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Since the protein coordinates were fixed in the above simulations, we were not able
to observe potential co-aggregation of both proteins and peptides. Next, we allowed
proteins to move in DMD simulations, but used smaller molecular systems for them to be
computationally tractable. We included 2 proteins and 2 peptides in the simulations (Fig.
4-7), and monitored the number of proteins forming a cluster to evaluate the corresponding
co-aggregation with the peptides. Averaging over 20 independent simulations, we
computed the average number of proteins in a protein-containing cluster, Np, as a function
of simulation time (Fig. 4-7A). Given only two proteins in these simulations, the value of
1 corresponded to the two proteins separated and 2 for the case of protein aggregation.
Starting from separated proteins, Np of the aLac-IAPP mixture increased to nearly 2 while
Np of the Lys-IAPP mixture fluctuated near 1. Two aLac tended to form one cluster but Lys
stayed more separated (Fig. 4-7B), as illustrated by snapshot structures from the
corresponding simulations (Fig. 4-7C,D). We also performed similar simulations and
analyses of 2 proteins interacting with 4 IAPP peptides and obtained similar results (Fig.
4-8); the tendencies of aLac co-aggregating with IAPP and Lys staying separated were
stronger, consistent with experimental observations. Specifically, aLac co-aggregated with
IAPP to form large amorphous aggregates while Lys binding stabilized the small molecular
weight oligomers that were highly toxic to HUVECs (Figs. 4-1,4-3).

65

Figure 4-9. Binding of proteins with IAPP amyloid fibril. (A) Binding frequencies of either
aLac or Lys with an IAPP fibril during the course of simulations. (B) Binding probability
of each IAPP residue in the fibril with either aLac or Lys was derived from the IAPP-
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protein complexes. Similarly, the binding probabilities of residues in aLac (C) and Lys (D)
with the IAPP fibril were also computed. The residues with peaks values were highlighted,
where the residue indices were re-numbered from 1 in each corresponding sequence. (E)
Normalized protein-fibril binding cluster sizes as a function of cluster index. The centroid
structures of the top cluster for both aLac-fibril and Lys-fibril binding were shown in the
inset. Both proteins and peptides were shown in cartoon representation with sticks and the
IAPP residues in the fibril were colored according their corresponding binding frequencies
to either aLac (orange) or Lys (purple).

We subsequently simulated binding of the two types of proteins with IAPP amyloid
fibril. The two-layered beta-sheet fibril structure with each protofibril containing ten IAPP
peptides were constructed based on solid-state NMR constraints.120 Considering the
system's complexity, only the unstructured loops and the sidechains of solvent exposed
residues in the beta-sheets in addition to proteins were allowed to move in the simulations.
We found that aLac elicited stronger binding to the fibril than Lys (Fig. 4-9A). The binding
of proteins with IAPP fibrils (Fig. 4-9) was very different from their binding with soluble
IAPP (Fig. 4-3). For example, aLac primarily bound to the charged IAPP residues in the
fibril (e.g., K1 and R11 in Fig. 3-9B), which is expected since IAPP amyloid with multiple
peptides forming in-registered beta-sheets was highly charged around these residues.
Similarly, the aLac residues with high binding probability to the fibrils were mainly
negatively charged residues (Fig. 4-9C). For the binding between Lys and the IAPP fibril,
the residues with high binding probabilities in either the fibril (Fig. 4-9B) or Lys (Fig. 4-
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9D) included both polar and hydrophobic residues. Most of the C-terminal region of IAPP
(except Y37) was buried at the protofibril interface of the fibril, thus avoiding interactions
with the proteins (Fig. 4-9B).

Figure 4-10. Centroid structures of the top two aLac-fibril binding clusters (A, B). Both
aLac (orange) and peptides were shown in cartoon representation with sticks. The IAPP
residues in the fibril were colored according their binding frequencies with aLac.
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Figure 4-11. Centroid structures of the top four Lys-fibril binding clusters (A-D). Both
Lys (purple) and peptides were shown in cartoon representation with sticks. The IAPP
residues in the fibril were colored according their binding frequencies with Lys.
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To characterize the binding structures of either aLac or Lys with the IAPP fibril,
we constructed the structural ensembles of protein-fibril complexes by evenly selecting
snapshot structures from the simulations: 3,079 snapshot structures for Lys-fibril binding
and 7,672 for aLac-fibril binding due to the stronger binding of aLac with the fibril (Fig.
4-9A). For each ensemble, we performed a clustering analysis with pair-wise center-ofmass distances of the proteins to group similar protein-fibril binding poses. With a cut-off
distance of 1 nm, we obtained 30 clusters for Lys and 35 for aLac and computed the cluster
size distributions normalized by the total number of structures in each ensemble (Fig. 49E). For aLac-fibril binding, the top two clusters contained ~45% of all snapshot structures
while the rest of the clusters had small number of structures (the centroid structures of the
top two clusters were shown in Fig. 4-10). In the case of Lys-fibril binding, the cluster sizes
were more evenly distributed (the centroid structures of the top four clusters were shown
in Fig. 4-11). Therefore, Lys tended to bind more evenly on the fibril surface while aLac
had more specific binding sites on the fibril surface. This result explains the experimentally
observed difference in fibril diameters remodelled by protein binding (Fig. 4-3C) – fibrils
evenly covered with Lys resulted into larger diameters compared to fibrils bound by aLac
at specific regions.
Because the fibrils were not allowed to move in our simulations, we could not
capture the experimentally observed softening of fibrils upon aLac binding, which was
likely due to the strong electrostatic-driven aLac-fibril binding (Fig. 4-9, 4-10). Given a
high number of negatively charged residues in aLac (8 Asp and 12 Glu) and the geometrical
incompatibility between the globular protein and the cylindrical fibril, such strong inter-
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molecular attractions may induce strain along the fibril, resulting in fibril bending and
reduced fibril persistence length (Fig. 4-3E).
Conclusion
We have applied ThT fluorescence assay, CD spectroscopy, TEM imaging, cell
viability assay and atomistic DMD simulations to examine the effects of protein binding
on IAPP amyloidosis, including IAPP aggregation kinetics and dynamics, fibril
remodelling and cytotoxicity. We found that soluble IAPP could bind to both cationic Lys
and anionic aLac, driven by either hydrophilic or hydrophobic interactions (Fig. 4-5). Since
IAPP peptide is intrinsically disordered with high conformational flexibility, IAPP could
bind many co-localizing proteins in general. Without imposing any prior assumptions into
DMD simulations, protein binding with aLac and Lys displayed drastically different effects
on IAPP self-association in silico due to their distinct physicochemical properties.
Specifically, aLac and IAPP co-aggregated forming a large IAPP-aLac molecular complex
(Fig. 4-1B), driven by strong binding affinity (Fig. 4-5) and opposite charges. The large
aggregates formed by IAPP and aLac mixture elicited low toxicity to HUVECs. Lys, on
the other hand, could bind and stabilize IAPP oligomers (Fig. 4-6B,D), where increased
electrostatic repulsion prevented further aggregation of these clusters (Fig. 4-7 & Fig. 4-8).
Stabilization of low molecular weight oligomers of IAPP by their associations with Lys
resulted in increased toxicity of IAPP as toxic oligomers were transiently formed (Fig. 43). Interestingly, protein binding of IAPP fibril - i.e. formation of amyloid coronae - always
reduced the relatively low toxicity of the fibril, suggesting a new mechanism for mitigating
IAPP toxicity in vivo.
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Figure 4-12. Binding of 6 IAPPs with 48 proteins of fixed positions. (A) Number of
unbound IAPP peptides averaged over independent simulations as a function of simulation
time. (B) Histogram of the number of peptides bound to either aLac, Lys, or their mixture
was computed from the last 12.5 ns of corresponding simulations. (C-E) Snapshot
structures of IAPP (cyan) peptides binding with either aLac (orange; C), Lys (purple; D),
or their mixture (E) where both peptides and proteins were in cartoon representation.

Given the over-abundance of globular proteins in the physiological medium (e.g.,
the blood circulation), we simulated 6 IAPPs interacting with 48 fixed proteins (Fig. 4-12).
Compared to the simulations of 6 IAPP with 6 fixed proteins at a 1:1 molar ratio (Fig. 4-
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6), we found that majority of IAPPs bound one protein as in a monomeric form (Fig. 412B-E). Therefore, despite the general binding of IAPP with globular proteins and the
potential of proteins in promoting toxic IAPP species at comparable protein/IAPP
concentrations, a crowed environment with abundant globular proteins may inhibit the
formation of IAPP oligomers. Further exploration is necessary to fully elucidate
environmental proteins that may contribute to IAPP toxicity both in the pancreas and in
circulation. Together, this new protein corona paradigm facilitates our understanding of the
fate and transformation of IAPP in vivo, which may have consequential bearings on IAPP
glycemic control and T2D pathology.
Materials and Methods
Materials
Human islet amyloid polypeptide (IAPP) (disulfide bridge: 2-7; MW: 3,906; 37residue: KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY) was obtained as
lyophilized powder from AnaSpec. Lysozyme (Lys) (from chicken egg white; MW: 14,300)
and α-lactalbumin (aLac) (calcium depleted, from bovine milk; MW 14,178) were obtained
from Sigma Aldrich. IAPP, aLac and Lys were weighed on a Cubis MSE balance (Sartorius,
0.01 mg resolution), dissolved in Milli-Q water (pH 6.5) to a concentration of 200 µM and
used immediately for zeta potential, ThT, TEM and viability assay sample preparations.
Pre-formed IAPP amyloids (30-60 days old in Milli-Q water, room temperature) were kept
at a stock concentration of 200 μM. Thioflavin T (ThT) dye (Sigma) was dissolved in MilliQ water to form a 250 μM stock solution immediately prior to use in ThT sample
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preparations. Calcein-AM dye (Sigma) was kept in a 1 mM stock solution in DMSO at -20
o

C.

Zeta potential
The zeta potentials of IAPP, Lys and aLac were determined using a dynamic light
scattering device (Zetasizer Nano S90, Malvern Instruments) at room temperature. The
concentration of IAPP was 25 μM while the concentrations of Lys and aLac were both 7.9
μM.
Thioflavin T assay
IAPP, aLac and Lys were added to a black/clear bottom 96 well plate (Costar) to a
final IAPP concentration of 25 μM, and final aLac and Lys concentrations of 25 μM,
representing IAPP:protein ratios of 1:1. Thioflavin T (ThT) dye (Sigma Aldrich) was added
to all wells to a concentration of 25 μM, and the remaining volume made up to 100 μL with
Milli-Q water. The plate was kept at 25 oC and read on a Flexstation 3 plate reader
(Molecular Devices) every 5 min for a total of 14 h (169 readings), with wells excited at
440 nm and the emission read at 485 nm.
Circular dichroism spectroscopy
IAPP, aLac and Lys at equimolar concentrations (25 μM) were read after 0 and 48
h incubation at room temperature on a Chirascan CD spectrometer (Applied Photophysics)
across a wavelength range of 190~260 nm. Final spectra were an average of three reads,
which were then normalised against background signal and, for IAPP:protein samples,
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against individual protein controls at each respective time point. The percentage of β-sheet
content in each protein was derived through deconvolution of normalised spectra using
CDNN software.
Transmission electron microscopy
IAPP, IAPP amyloids, aLac and Lys (25 μM; IAPP:proteins = 1:1) were incubated
in Milli-Q water at 25 oC for 24 h. A 10 μL aliquot was then taken and placed on 400 mesh
carbon-coated formvar copper grids (ProSciTech) that were glow-discharged for 15 s to
promote hydrophilicity. Sample adsorption was undertaken for 60 s, then drawn off on
filter paper. Grids were washed twice in 10 μL Milli-Q water. 5 μL of 1% uranyl acetate
(in water) was utilized to twice-stain grids, by touching one droplet and immediately
drawing the stain off, and then placing the grid atop the second droplet to stain for 15 s.
TEM images were obtained on a Tecnai TF20 transmission electron microscope (FEI) with
an UltraScan 1000 (2k×2k) CCD camera (Gatan).
Statistical analysis of IAPP fibrils upon protein binding
The distributions of fibril diameters for IAPP amyloids, amyloid-aLac and amyloidLys were determined through randomly sampling 100 points on the fibrils in TEM.
Measurements were undertaken using Digital Micrograph software (Gatan), and Gaussian
modelling of fibril distributions was applied in Prism (GraphPad). Unpaired t-tests,
utilising the Holm-Sidak method for multiple comparisons, were used to calculate
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statistical significance. Values wherein p < 0.05 were considered to be statistically
significant.
The mesoscopic parameters of fibril persistence length (λ) and contour length (l) in
the presence and absence of the proteins were analyzed with software FiberApp.112 The
FiberApp open-source code was developed from statistical polymer physics for the
structural analysis of filamentous and macromolecular objects. The persistence length λ
reflects the rigidity of a polymer and is mathematically defined via the bond correlation
function (BCF) in 3D or 2D as the length over which angular correlations in the tangential
direction decrease by a factor of e. Here the λ values of IAPP fibrils were estimated from
the average values determined by the BCF, mean-squared end-to-end distance (MSED) and
mean-squared midpoint displacement (MSMD) methods. The contour length corresponds
to the end-to-end length of a polymer along its contour. The values of persistence length
and contour length were obtained based on statistical analysis of 290 fibrils.
Viability assay
IAPP, IAPP amyloids, aLac and Lys (100 μM) were incubated in Milli-Q water for
24 h at 25 oC prior to addition to cells. HUVECs (Lonza) were seeded into a black/clear
bottom 96 well plate (Corning) at a density of 1.0 x 105 cells/well in 200 μL EGM (Lonza)
and incubated overnight (37 oC, 95% humidity, 5% CO2). Media was refreshed and preincubated IAPP, IAPP amyloids, aLac and Lys were added to final concentrations of 25
μM. For control cells, an equal volume of Milli-Q water was added to each well. Samples
were added to wells in triplicate and incubated for 24 h (37 oC, 95% humidity, 5% CO2).

76

Bright-field images were taken prior to calcein-AM viability testing with a Nikon TS100
bright-field microscope, equipped with a DS-Fi1 CCD camera (Nikon) and Digital Sight
software (Nikon).
The calcein-AM live cell assay was used to provide quantitative data on cell viability.
The calcein-AM dye is colorless in aqueous solution, but fluoresces brightly in the green
spectrum when cellular esterases cleave off the AM group. In brief: media was aspirated
from wells, cells were gently washed 3× in warm HBSS (Gibco), and 100 μL aliquots of 2
μM calcein-AM dye in HBSS were added to each well. The dye was incubated with cells
for 30 min at 37 oC before endpoint fluorescence was read (excitation: 485 nm; emission:
538 nm) on a Flexstation 3 plate reader (Molecular Devices). Though lysozyme is capable
of non-specific esterase activity121, a separate control confirmed the fluorescence of
calcein-AM was not affected.
Statistical analysis of viability assay
Percentage viability of cells was calculated through direct comparison of calceinAM fluorescence intensity with control cells (100% viable) after correcting for background
fluorescence. Error bars represent the standard error of mean. A one-way ANOVA utilising
Tukey’s multiple comparisons test was performed to test for statistical significance. Values
were considered statistically significant if p < 0.05.
DMD simulations
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DMD is a special type of molecular dynamics algorithm where conventional
continuous potentials are replaced by optimized step-wise potential functions. A more
comprehensive description of the DMD algorithm was published elsewhere122,123. In brief,
the united-atom model represented all molecules where all heavy atoms and polar hydrogen
atoms were explicitly modelled. We applied an implicit solvent model in our system. The
interatomic interactions included van der Waals, solvation, electrostatic interactions and
hydrogen bond124. The solvation energy was adopted by the Lazaridis-Karplus implicit
solvent model, EEF1125. The distance- and angular-dependent hydrogen bond interaction
was modelled using a reaction-like algorithm126. Screened electrostatic interactions were
computed by the Debye-Hückel approximation. A Debye length of 1 nm was used by
assuming a water dielectric constant of 80 and a monovalent electrolyte concentration of
0.1 M. The Anderson’s thermostat was used to maintain constant temperature.
In DMD simulations, the unit of time [T] is determined by units of mass [M], length
[L], and energy [E], which are Dalton (1.66 x 10 -24 g), angstrom (10-10 m), and kcal/mol
(6.9 x 10-22 joule), respectively. Using the relationship [T] = [L]√[M]/[E]as in classical
MD, the time unit is approximately 50 fs.124 All simulations were done with customized
DMD software, while a similar version with the same force field is freely available via
Molecules In Action, LLC (www.moleculesinaction.com). Our software is available upon
request.
The structural coordinates for IAPP peptides were obtained from the protein data
bank (Human islet amyloid peptide code 2L86, native human lysozyme code 1REX and
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bovine alpha lactabumin 1F6S respectively). For all these proteins and peptide as well as
amyloid fibrils, basic and acidic amino acids were assigned charges corresponding to their
titration states at physiological condition, i.e. Arg and Lys residues were assigned +1, Asp
and Glu were assigned -1, while His was neutral. Counter ions (Cl-) or sodium (Na+) were
implemented to maintain the net charge of the systems zero and accounted for possible
counter–ion condensation.
We used the solid-state NMR derived constraints and the corresponding pentamer
fibril models from Luca et al.120 to reconstruct a larger fibril model with two decamer
protofibrils forming a two-layered fibril. Specifically, side chains of Gln10, Leu12, Asn14
and Leu16 were located inward to the beta-sheet formed by residues 28-37. The side chains
of Arg11, Ala13 and Phe15 in the protofibril were buried to form the fibril. We used a
central peptide from the pentamer model shared by the Tycko group and applied
translational and two-fold rotational symmetries to reconstruct the larger fibril. Using the
same proximity constraints, we performed DMD simulations to relax the model structure
until the system’s potential energies reached equilibrium at 300 K. As the model fibril
comprised of 20 IAPP monomers, we fixed most of the residues/atoms of IAPPs to reduce
simulation cost. All atoms except residues 1-4 and side chains of residues 9,11,15,1718,20-21 and 37 were fixed in simulations.
All simulations were conducted at 300 K. To maintain the same peptide
concentration in the systems of protein-peptide ratios 6:6 and 2:2, cubic simulation box
with dimensions of 137.0 Å and 95.0 Å were used correspondingly. We used a box size of
74.3 Å for the system of one protein and one peptide, 240.0 Å for 6 peptides with 48
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proteins, and 150 Å for protein binding with fibril. The periodic boundary condition was
applied in all simulations. For data analysis, we used an inter-atomic distance cutoff of 5.0
Å to define an atomic contact.
We

used

a

hierarchical

clustering

program,

oc

(www.compbio.dundee.ac.uk/downloads/ oc), to group similar protein binding poses with
the fibril. Based on an input pair-wise distance matrix that was the center-of-mass distances
of the protein on the fibril surface in our study, a hierarchical clustering algorithm
iteratively joined the two closest clusters into one cluster according to the distances
between two clusters. The “cluster distance” was computed based on all pairwise distances
between elements of the two corresponding clusters, which can be the minimum, maximum,
or the mean of all these values. In this study, we used the mean to compute the distance
between two clusters. The centroid structure of each cluster was selected as the one with
the smallest average distance to other elements in the cluster.
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CHAPTER FIVE
MICELLAR LYSOPHOSPHATIDYLCHOLINE INHIBITS THE AGGREGATION OF
HUMAN ISLET AMYLOID POLYPEPTIDE
Introduction
Human islet amyloid polypeptide (IAPP) is an endocrine hormone that, in its
monomeric form, regulates glucose metabolism in cooperation with insulin. However,
IAPP is aggregation prone sans the protection of insulin, physiological metal ions or low
pH,1-6 and accumulating evidence has implicated IAPP amyloid aggregation as a hallmark
of pancreatic β-cell death and type-2 diabetes (T2D), a disease impairing millions of people
worldwide with profound social and economic implications.
Oligomeric IAPP has been widely acknowledged as the toxic species based on in
vitro and animal studies.1,7 Upon release into the bloodstream IAPP is exposed to a myriad
of plasma proteins and lipids, yet the impact of such exposure on IAPP conformation and
toxicity has rarely been studied. Recently we have proposed the concept of protein corona
for elucidating the physicochemical and structural transformations of IAPP in circulation.21
In this study we examined the effects of zwitterionic lysophosphatidylcholine (LPC) at
both below and above its critical micelle concentration (CMC, 40-50 μM)22 on IAPP
aggregation. LPC is the most abundant single-tailed phospholipid in the blood (234 μM)23
as well as a signaling molecule in the cell membrane. At concentrations above the CMC,
such as in the blood, LPC molecules render ultra-small micelles (~4 nm in diameter)24,25 in
size similar to that of sodium dodecyl sulfate (SDS). From the perspective of a model
membrane the zwitterionic LPC micelles mimic the largely neutral pancreatic β-cell
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membranes (97.5% neutral, plus 2.5% anionic lipids)26 more closely than the anionic SDS
that has been used as a model system for examining protein-membrane interactions.
The fibrillization of IAPP in the presence of linear and micellar LPC was quantified
by a thioflavin T (ThT) kinetic assay and high-resolution transmission electron microscopy
(TEM). The changing secondary structure of IAPP in the presence of linear and micellar
forms of the lipid was probed with circular dichroism (CD) spectroscopy. A surprising
inhibition effect of LPC micelles on IAPP amyloid aggregation was revealed, characterized
by a prolonged lag time, a reduction in the β-sheet content at saturation, and sparse
formation of soft, braided IAPP fibrils. Atomistic discrete molecular dynamic (DMD)
simulations27 were performed to provide molecular details of IAPP-LPC interaction. Upon
binding the micelles, the C-terminal region of IAPP that is unstructured in solution28 started
to adopt an α-helical conformation. The hydrophobic interfaces of the amphiphilic N- and
C-terminal helixes were buried at the lipid head-tail interface, forming a well-defined
IAPP-micelle complex to inhibit the self-association and aggregation of IAPP.

Results and discussion
Effects of LPC binding on IAPP fibrillization and remodeling - experiments
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Figure 5-1. Effects of micellar (> CMC) and non-micellar (< CMC) LPC on IAPP
fibrillation and amyloid remodeling. Concentrations of IAPP (25 µM), LPC < CMC (25
µM) and > CMC (2 mM) were fixed in all experiments. (A) ThT fluorescence assay of
IAPP and LPC alone (both above and below the CMC) or as mixed samples, with sigmoidal
least-squares fit (dotted lines); error = SEM. (B) TEM imaging of IAPP and IAPP amyloids
after 24 h incubation with or without LPC, scale = 100 nm. (C) IAPP secondary structures
in the presence and absence of LPC as determined through circular dichroism spectroscopy.
Lines are intended to guide the eye. (D) Diameter frequencies of IAPP amyloid fibrils with
Gaussian least-squares fit, **** p < 0.0001 (one-way ANOVA with Tukey’s correction). (E)
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HEK 293 cell toxicity induced by monomeric IAPP and IAPP amyloids in the presence (+)
and absence (-) of LPC < CMC, in addition to cells without IAPP treatment (Control).
Incubation: 24 h, error = SEM, **** p < 0.0001 (two-way ANOVA).

Biophysical characterizations revealed the differential effects of micellar and nonmicellar LPC on IAPP fibrillization, and additionally, their capacities in remodeling of
mature IAPP amyloids (Fig. 5-1). Native fibrillization of IAPP, which forms long, semiflexible amyloid fibrils in aqueous solution over 24 h, was notably inhibited by micellar
LPC (Fig. 5-1B). ThT fluorescence indicated a reduction in the β-sheet content formed by
IAPP in the presence of micellar LPC by 24 h, compared to the IAPP control (Fig. 5-1A).
Non-micellar LPC induced a lag time of only ~10 min and the saturation point was reached
~2 h before the IAPP control. This effect has also been observed with the Alzheimer'srelated amyloid-β, where LPC below the CMC was capable of reducing the fibril lag and
elongation times of amyloid-β1-42, yet showed no notable increase in fibrillization after
saturation was reached in each case.29 Anionic non-micellar lipids, including SDS30 and
lysophosphatidic acid (LPA)31 have demonstrated the capacity to promote fibrillization and
fibril elongation of β2-microglobulin (β2M) at a neutral pH, though zwitterionic LPC did
not mediate any significant effect.
The interaction of micellar LPC with IAPP, in contrast, greatly reduced IAPP
fibrillization, both in terms of fibrillization kinetics and overall amyloid formation by 24 h.
CD spectroscopy revealed the transition of peptide secondary structure from random coils
to β sheets over 24 h (Fig. 5-1C). In the presence of non-micellar LPC, an increase in β-
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sheet content of ~15% was observed for IAPP by 24 h, while the α-helical content (< 10%)
showed negligible variations over the experimental period. In contrast, interactions of IAPP
with LPC micelles induced an immediate transition from β sheets to α helices (39.2%).
Within the IAPP-LPC micelle complex, IAPP random coils remained stable over 24 h
(~33%). In contrast, Patil et al. observed that upon complexation with SDS micelles, IAPP
residues 5-28 were present in the α-helical conformation, with residues 5-19 embedded in
the hydrophobic core, and the known amyloidogenic region (residues 20-29) positioned on
the surface of the micelle at the lipid-solvent interface.13

Figure 5-2. TEM image of LPC micelles at 2 mM (>CMC). Scale: 10 nm.
Given the limited capacity for inter-peptide interactions between micelle-bound
IAPP, disruption of IAPP fibrillization is expected. Indeed, visualization of IAPP amyloid
fibrils after 24 h in aqueous solution demonstrated significant structural polymorphism of
IAPP fibrils in the presence of micellar LPC by TEM imaging (Fig. 5-1B) and subsequent
analysis of fibril diameter (Fig. 5-1D). Large, braided amyloid fibrils larger than 30 nm in
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diameter were observed (Fig. 5-1B), displaying a significantly broadened distribution
compared with the IAPP control or IAPP treated with non-micellar LPC (Fig. 5-1D),
though fewer fibrils were seen. The fibrils appeared softer, with a persistence length of 458
± 13 nm based on FiberApp statistical analysis,32 compared with that of 2,885 ± 60 nm for
the IAPP control.33 Below the CMC, LPC remodeled amyloid fibrils into filaments of
thinner width (Fig. 5-1D). Micellar LPC (Fig. 5-2, 4-5 nm in size) did not remodel preformed fibrils, but similarly to their effect on fibrillating IAPP, individual fibrils were
observed to closely associate, belying the 'glue-like' effect of LPC micelles on mature
amyloids. In vitro experiments in a human embryonic kidney 293 (HEK293) cell line
showed that LPC below the CMC was capable of significantly reducing IAPP-mediated
cytotoxicity (Fig. 5-1E), through IAPP-LPC binding whose mechanisms were examined
by computer simulations.
Effects of LPC binding on IAPP structure by discrete molecular dynamics simulations
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Figure 5-3. IAPP-LPC micelle interaction. (A) Average contact number between pair-wise
IAPPs, Ncontact (top) and binding frequency between IAPP and LPC micelle, Pbind (lower)
as a function of time. (B) Binding frequency Pbind of each IAPP residue with hydrophobic
and hydrophilic regions of LPC micelle derived from the IAPP-LPC complexes. Residues
with strong binding to the hydrophobic core of LPC micelle are highlighted as sticks in a
representative micelle-bound IAPP structure (inset). (C) Secondary structure contents,
Psecond, of IAPP with and without LPC micelle. (D) The α-helix propensity Phelix of each
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IAPP residue with and without LPC micelle. (E, F) The 2D-PMF of IAPP with and without
LPC micelle at T = 300 K as a function of radius of gyration, Rg, and the number of residues
in helical conformation, Nhelix. The typical structures corresponding to energy basins
indicated by arrows are shown as inset where IAPP (cyan) is illustrated in carton and LPC
micelle (orange) in spherical representation.

Each LPC micelle comprised of 50 LPC lipid monomers was pre-assembled and
equilibrated by DMD simulations, rendering a micellar diameter of ~4 nm (Methods,
Supporting Information). Simulations of IAPP peptides and LPC micelles were performed
at a 2:2 ratio to investigate the effect of LPC micelles on IAPP self-association. The control
simulations of two IAPPs alone were carried out at the same concentration. Averaging over
20 independent simulations, the self-association of IAPP was monitored by computing the
average number of atomic contacts between the two IAPPs as well as the binding between
the IAPP and the micelle as a function of time (Fig. 5-3A). Indeed, the self-association of
IAPPs was significantly reduced (Fig. 5-3A, upper panel) due to their higher tendency to
bind micelles (Fig. 5-3A, lower panel). To characterize the interactions of LPC micelles
with IAPP, the binding frequency of each IAPP residue with either the hydrophobic tails
or hydrophilic heads of LPCs was calculated (Fig. 5-3B). The hydrophobic tails of LPCs
in the micelle core preferentially bound to the hydrophobic residues of IAPP, i.e., L12, F15,
L16, F23, I26, L27 and Y37 (Fig. 5-3B inset). The hydrophilic residues of IAPP had higher
binding frequencies with the phosphorylcholine heads of LPCs than their hydrophobic tails,
indicating a stable IAPP-micelle complex formation by burying the hydrophobic IAPP
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residues into the hydrophobic core of the LPC micelle and exposing the hydrophilic IAPP
residues on the surface. In the presence of LPC micelles, the overall helical content of IAPP
increased while the β-strand and turn contents decreased compared to IAPPs alone (Fig. 53C), which is consistent with the CD experiment (Fig. 5-1C). In particular, the increased
α-helix propensities were mainly in residues 18-29, approximately corresponding to the
IAPP amyloidogenic region (Fig. 5-3D).34 To better characterize the structural properties
of IAPPs in the presence and absence of LPC micelles, a two-dimensional potential of
mean force (2D-PMF, or effective free energy) was computed with respect to the radius of
gyration (Rg) and the number of residues in helix conformations (Nhelix) (Fig. 5-3E, 5-3F),
𝑃𝑀𝐹 =  −𝐾𝐵 𝑇𝑙𝑛𝑃(𝑅𝑔 , 𝑁ℎ𝑒𝑙𝑖𝑥 ) + C, where KB is the Boltzmann constant, T the simulation
temperature at 300 K, and C a constant set to render the lowest PMF value at zero.
Compared to the control simulations of an IAPP dimer, the energy basins of IAPPs in the
presence of LPC micelles shifted toward larger Nhelix values with a new basin emerging at
Nhelix ~12 and larger Rg values. By burying the hydrophobic residues of the amphiphilic
helices at the N- and C-termini in the micelle, IAPPs became extended on the micelle
surface, while IAPPs alone formed a more compact dimer structure stabilized by interchain hydrogen bonds and hydrophobic interactions (snapshots in the inset of Fig. 5-3E, F
corresponding to the indicated PMF basins). The simulations suggest that LPC micelles
prevented IAPP self-association and aggregation by stabilizing IAPP monomers in the
IAPP-micelle complexes. In addition, the small size of LPC micelles and their
correspondingly large curvature also stabilized the surface-bound IAPPs in the monomeric
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form, hence preventing formation of -sheet rich amyloid fibrils due to the geometric
impartibility between a flat -sheet and the highly curved binding surface.

Figure 5-4. IAPP-soluble LPC interaction. (A) Average number of IAPP clusters as a
function of simulation time in the presence and absence of LPCs. (B) Mass-weighted
histograms of IAPP cluster sizes computed from the last 25 ns of corresponding simulations.
(C) Binding frequency, Pbind, of each IAPP residue with hydrophobic and hydrophilic
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regions of LPC derived from the IAPP-LPC complexes. For comparison, binding with the
hydrophobic region of LPC micelle is also shown as a dash line. (D) Snapshot structures
along a DMD trajectory showing the co-aggregation process, where IAPPs (cyan) are in
carton representation and LPCs in spherical representation.

The effect of LPC monomers on IAPP self-association was examined by simulating
the self-assembly of six IAPP peptides in the presence and absence of 24 initially isolated
LPC molecules (Methods, Supporting Information). To quantify the self-association of
IAPPs, a single-linkage clustering analysis of snapshot structures along the simulation
trajectories was performed: two molecules formed a cluster if they were in contact (i.e.,
making at least one intermolecular contact) and a molecule belonged to a cluster if it was
in contact with any of the member molecules. In the presence of LPCs, the average number
of IAPP-containing clusters rapidly dropped from 6 to 2 while the control simulations still
had ~4 clusters after 200 ns (Fig. 5-4A). Using the last 25 ns of all simulations, we
compared the distribution of mass-weighted IAPP cluster sizes in the presence and absence
of initially isolated LPC monomers, where the presence of LPC monomers enhanced the
self-association of IAPPs for larger oligomers (Fig. 5-4B). Compared to LPC micelles,
these initially isolated LPCs had similar binding profiles to IAPP residues, but with overall
stronger hydrophobic interactions (Fig. 5-4C) due to a higher accessible hydrophobic
surface per lipid. The snapshots from 6 IAPPs with initially isolated LPCs illustrated the
process of co-aggregation of IAPPs with LPCs (Fig. 5-4D). IAPP initially bound to one or
several LPCs due to strong hydrophobic interaction and formed small and then large IAPP-
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LPC complexes with increased hydrophobic surfaces (150 & 200 ns; Fig. 5-4D). Therefore,
these results suggest that the presence of LPC monomers accelerated the self-association
of IAPPs. Since the timescales accessible to atomistic DMD simulations were much shorter
than the aggregation kinetics in experiments, no significant changes in IAPP secondary
structure were observable with and without LPCs (data not shown).

Figure 5-5. IAPP amyloid-soluble LPC interaction. (A) Mass-weighted histograms of LPC
cluster sizes in solution and bound to fibril (inset) computed from IAPP amyloid fibril and
LPC simulations. (B) Binding probability, Pbind, of each IAPP residue in the fibril with
LPC. Two main binding sites for LPC on IAPP amyloid fibrils correspond to half-worm
like (C) and micelle (D) morphologies. The fibril is colored by the binding probability of
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IAPP residues with LPC: orange (0.7-1), yellow (0.3-0.7), grey (0.1-0.3) and blue (<0.1)
indicating high to low binding probabilities. LPCs are highlighted as spherical
representation in panel (C) from top view to show LPCs fit onto groves between
consecutive β-strands.

The binding of LPC lipids with a two-layered IAPP amyloid fibril was examined.
The fibril model consisted of 40 peptides, reconstructed based on solid-state NMR
constraints.35 30 independent simulations of 160 LPC monomers with randomly assigned
initial positions and orientations around the fibril were performed, where the model fibril
was fixed and LPCs were allowed to move freely. The distributions of LPC clusters in
solution and bound to the fibril were calculated (Fig. 5-5A). In solution, the lipids selfassembled into various clusters or micelles with still isolated monomers. LPC could also
bind the fibril and form larger clusters on the fibril surface (e.g., the large cluster of ~100
LPCs in the inset of Fig. 5-5A). The binding profile of LPCs with different IAPP residues
in the fibril (Fig. 5-5B) was highly selective compared to free IAPPs (Figs. 5-3D & 5-4C).
Interestingly, residues with high binding frequencies to LPCs formed four consecutive
surface patches on the fibril surface or two LPC binding sites due to the two-fold symmetry
of the fibril along the axis. One of the binding sites was around hydrophobic residues L12,
F15, V17, and H18, forming a flat hydrophobic surface patch on the fibril surface (Fig. 55C). A large amount of LPCs bound to this site (i.e., the largest LPC cluster of ~100 lipids
in Fig. 5-5A) and formed a half-worm like morphology. LPC monomers could fit onto the
groves between two consecutive β-strands (e.g., LPCs highlighted in spherical
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representation in Fig. 5-5C). The other binding site (formed by residues N3, A5 and Y37)
was smaller and curved and the bound LPCs remained in the micelle morphology (Fig. 55D). Although simulations with the fibril fixed could not capture remodeling of the fibril
by LPCs, the strong LPC-fibril binding suggests that LPC could coat the fibril and bundle
multiple fibrils into a braided structure as observed in TEM (Fig. 5-1B). This can also
explain the slightly reduced ThT intensity but increased β sheet content observed for IAPP
fibrillization in the presence and absence of LPC < CMC (Fig. 5-1A vs. 5-1C, middle
panel), as the strong binding of LPC monomers onto IAPP fibrils and protofibrils would
sterically hinder ThT dye from binding thereby reducing its fluorescence. The combined
ThT, CD, TEM and DMD results suggest that LPC monomers accelerated IAPP binding.

Conclusion
The uncovered phenomenon of IAPP aggregation inhibition by micellar LPC offers
a new mechanism to the existing models of IAPP stabilization by insulin, low pH and metal
ions.1 Interestingly, although not directly related to this study, it has been shown in the
literature that whey protein α or β caseins, usually present in the form of micelles through
mutual hydrophobic and electrostatic interactions, show a chaperone-like activity in
inhibiting amyloid beta and insulin from aggregation through mechanisms not yet
understood.36,37 Differently from cell membranes and SDS micelles that are net negative,
zwitterionic LPCs readily disperse in water as ultrasmall micelles and subsequent interact
with IAPP to halt the latter’s aggregation. These unique physicochemical characteristics of
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LPC may be crucial to IAPP stabilization in vivo and instructive to the design and
development of small molecules and nanoparticles against amyloidosis.
Materials and Methods
Materials
Human islet amyloid polypeptide (IAPP; 37 residues, 2-7 disulfide bridge, 3.9
kDa, >95% pure by HPLC) was obtained in lysophilized monomeric form from AnaSpec,
and prepared in Milli-Q water at a stock concentration of 200 µM at room temperature with
mixing immediately prior to use. Mature IAPP amyloids were aqueous solutions of IAPP
incubated for more than 24 h. Thioflavin T (ThT) dye and L-α-Lysophosphatidylcholine
(LPC; from Glycine max, >99% pure by TLC) were purchased from Sigma-Aldrich. LPC
derived from soybean is primarily composed of unsaturated C-18 fatty acids; typically 4060% linoleic, 25-30% palmitic, 10-12% oleic, 7-10% stearic and 4-6% linolenic acid.
Thioflavin T (ThT) assay
IAPP alone (25 µM) or in the presence of micellar and non-micellar LPC was mixed
with 25 µM ThT dye in a black/clear bottom 96-well plate (Costar), with the remaining
volume made up to 100 µL with Milli-Q water where necessary. ThT fluorescence
(Excitation: 440 nm/ Emission: 485 nm) was then read every 10 min for 24 h (144 time
points) on an EnVision plate reader (Perkin Elmer). Error represents the standard error of
mean of two independent experiments. Data was fit to a sigmoidal curve (least squares)
using Prism (GraphPad).
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Transmission electron microscopy (TEM) and analysis
Carbon-coated formvar copper grids (400 mesh, ProSciTech) were glow discharged
to promote hydrophilicity. A 10 µL aliquot of IAPP (25 µM) in the presence or absence of
LPC was placed on the grid and allowed to adsorb for 60 s. The remaining solution was
then drawn off and the grid washed twice in 10 µL of Milli-Q water. The grid was then
touched to 5 µL 1% uranyl acetate (in Milli-Q water), the solution immediately drawn off,
and the grid then placed onto a 5 µL droplet of 1% uranyl acetate to stain for 15 s. Any
remaining liquid was then drawn off and the sample allowed to dry. Grids were imaged
using Tecnai TF20 (FEI) and JEOL 2000FX transmission electron microscopes. Fibril
diameter analysis was undertaken using GMS 3 (Gatan), with the sample size as 150 data
points. Statistical analysis was performed with Prism (GraphPad), utilising a one-way
ANOVA with Tukey’s correction. Statistical significance was determined as p < 0.05.
Circular dichroism (CD) spectroscopy

Figure 5-6. Normalized far UV circular dichroism spectra of IAPP (25 µM) in the presence
of LPC above and below its critical micelle point (CMC) over 24 h.
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Experiments were performed on a Chirascan CD spectrometer (Applied
Photophysics), with spectra read from 190-260 nm. Prior to sample loading, a baseline with
no cuvette was run. 300 µL of 25 µM IAPP in Milli-Q water, alone or in the presence of
LPC above (2 mM) and below (25 µM) the CMC, was placed in a cuvette with a 0.1 cm
pathlength and CD analysis was run at 0 h, 2.5 h and 24 h time points. Between samples,
cuvettes were washed more than 5× with distilled water. Reads are an average of 3 repeats.
Raw data were offset to zero and normalized against the spectra of Milli-Q water for IAPP
spectra, and against LPC alone at each respective concentration for IAPP-LPC mixed
samples (Fig. 5-6). Data were then de-convoluted with CDNN software to give a final
relative percentage content of secondary structure.
Viability assay
IAPP (200 µM) were incubated in Milli-Q water for 24 h at 25 ºC to form IAPP
amyloid stock solution. To promote cell adhesion, a black/clear bottom 96-well plate
(Corning) was coated with 100 µL of 0.01% poly-L-lysine solution (Sigma-Aldrich) for 30
min at 37 ºC, with wells then washed 3× in DPBS. Human embryonic kidney 293 (HEK
293; ATCC, CRL-3216) cells were then seeded at a density of 1.0×104 cells/well in 150
µL complete DMEM (Sigma-Aldrich, 10% FBS) media and incubated overnight at 37 ºC
and 5% CO2. Media was then aspirated and 100 µL fresh DMEM (Sigma-Aldrich, 10%
FBS) was added to wells. 10 µL of 1 µM propidium iodide (PI; Excitation: 550-570
nm/Emission: 580-650 nm) solution in DMEM was added to each well and incubated for
15 min at 37 ºC and 5% CO2. IAPP, IAPP amyloids, LPC, IAPP+LPC (1:1) and IAPP
amyloids + LPC (1:1) (100 µM stock solution) were then added to the wells to obtain final
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concentrations of 25 µM. The plate was incubated for 24 h at 37 ºC and 5% CO2, and then
imaged using an Operetta high throughput microscope (Perkin-Elmer, Germany). Captured
images were analyzed using Harmony 4.1 software (Perkin-Elmer) to determine the
percentage of PI positive cells through comparing the total amount of cells mapped by
digital phase contrast with the amount of PI-positive nuclei, as representative of cell death.
Statistical significance was calculated using a two-way ANOVA. Values wherein p < 0.05
were considered to be statistically significant.
Discrete molecular dynamics (DMD) simulation methods
DMD is a special type of molecular dynamics algorithm where conventional
continuous potentials are replaced by optimized step-wise potential functions.38,39 A more
comprehensive description of the DMD algorithm was published elsewhere.27 In brief, the
united-atom model represents all molecules where all heavy atoms and polar hydrogen
atoms are explicitly modeled. An implicit solvent model was adopted in our system. The
interatomic interactions included van der Waals, solvation, electrostatic interactions and
hydrogen bond. The solvation energy was adopted by the Lazaridis-Karplus implicit
solvent model, EEF1.40 The distance- and angular-dependent hydrogen bond interaction
was modeled using a reaction-like algorithm.41 Screened electrostatic interactions were
computed by the Debye-Hückel approximation. A Debye length of 1 nm was used by
assuming a water dielectric constant of 80 and a monovalent electrolyte concentration of
0.1 M. The Anderson’s thermostat was used to maintain constant temperature.
The structural coordinates for IAPP peptides were obtained from the protein bank
(PDB code: 5MGQ). For peptides and LPC, basic and acidic amino acids and nitrogen
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were assigned charges corresponding to their titration states at physiological condition, i.e.
Arg and Lys residues were assigned +1, Asp and Glu were assigned -1, while His was
neutral. Counter ions (Cl-) were added to maintain the net charge of the systems zero and
accounted for possible counter-ion condensation.

Figure 5-7. IAPP amyloid fibril structure with a 1.5-degree twist between consecutive
IAPP beta-sheet with carton representation.

A large fibril model was constructed with 40 IAPPs forming a two-layered fibril
using the solid-state NMR-derived constraints,35 which was assigned a 1.5-degree twist
between consecutive IAPP beta-sheets. Specifically, side chains of Gln10, Leu12, Asn14
and Leu16 were located inward to the beta-sheet formed by residues 28-37. The side chains
of Arg11, Ala13 and Phe15 in the protofibril were buried to form the fibril (Fig. 5-7). Using
the same proximity constraints, DMD simulations were performed to relax the model
structure until the system’s potential energies reached equilibrium at 300 K. As the model
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fibril comprised of 40 IAPP monomers, the fibril was fixed during DMD simulations of its
binding with LPCs.
All simulations were conducted at 300 K. To maintain the same peptide
concentration in the systems of LPC monomers and micelles interacting with peptides
(molar ratios of 24:6 and 2:2, respectively), cubic simulation boxes with equal dimensions
of 183.0 and 126.8 Å were used correspondingly. The periodic boundary condition was
applied in all simulations. For each molecular system, 20 independent simulations were
performed with different initial inter-molecular distances and orientations to avoid bias.
For data analysis, an inter-atomic distance cutoff of 5.0 Å was used to define an atomic
contact.
By initially positioning linear LPCs evenly in a spherical arrangement with the tails
pointing inwards and heads outwards, relaxation simulations were performed at 300 K. The
equilibrated values of radius of gyration, Rg, were evaluated for micelles with 25 to 60
LPCs, with intervals of 5 for a total of 8 systems. Using the simple relationship between
radius r and Rg, 𝑟 = √5/3𝑅𝑔, we found that 50 LPCs resulted in a spherical micelle
structure of ~4 nm in diameter. The pre-formed micelle structure was used to study its
effect on IAPP self-association.
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CHAPTER SIX
MORPHOLOGICAL DETERMINANTS OF CARBON NANOMATERIALSINDUCED AMYLOID PEPTIDE SELF-ASSEMBLY
Introduction
Carbon nanomaterials (CNMs) including fullerene
130,131

127

, nanotube

128,129

and graphene

have been explored for numerous applications in energy, computing, environment

and medicine. CNMs are also widely used as building blocks for hybrid nanocomposites
130,131

. To enable their broad applications in bionanotechnology, CNMs can be hybridized

with biomacromolecules

132

to improve their aqueous solubility

133

, lower their cellular

toxicity 134 for tissue engineering and drug delivery 135–137, and harness novel functionalities
138

. Among various biomacromolecules, proteins are highly advantageous due to their

capability of conjugation with CNMs

139,140

, biological compatibility

141,142

, wide

availability 143, great chemical and structural varieties 144. In particular, amyloid nanofibers
self-assembled by proteins and polypeptides have drawn many attentions due to their
unique nanostructures

145,146

and high designability in the amino acid sequence space.

Traditionally associated with a long list of amyloid diseases (e.g., Alzheimer's disease
147,148

, Parkinson's disease

149

, and type-2 diabetes

150

) and also functional

151,152

roles in

biology, amyloid fibrils have been discovered as building blocks for bionanotechnology 153
and used to develop hybrid CNMs for novel applications. Conjugating β-lactoglobulin
amyloid fibrils with sulfonated multi-walled carbon nanotubes (MWCNTs) via both
covalent cross-link and physical π–π interactions, Li and Mezzenga

154

developed

biocompatible, pH-responsive, and fully fibrous hydrogels far below the gelling
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concentration of amyloid nanofibers. Li et al.

155

hybridized β-lactoglobulin amyloid

nanofibrils with graphene oxide to fabricate biodegradable nanocomposites with shapememory and enzymatic sensing properties. While many of these works offered useful
insights to the complex interactions between specific types of amyloid peptides and CNMs,
the parameter space of CNMs (e.g., dimension, chirality, and curvature) and also the
sequence space of amyloid peptides are very large and thus the physicochemical
determinants of amyloid peptide-CNM interactions including the assembly structures and
dynamics are still unknown. Such a knowledge gap hinders the development of this novel
class of hybrid nanomaterials and limits their broad applications.
Here, we attempt to fill the knowledge gap by investigating the self-assembly of two
types of amyloid peptides on the surface of CNTs with different chirality and radii
(including graphene nanosheet for infinite radius) using atomistic discrete molecular
dynamics (DMD) simulations complemented with transmission electron microscopy (TEM)
imaging. DMD is a rapid and predictive MD algorithm, widely used to study proteins 156,
amyloid aggregation

128

, nanoparticles and Nano-Bio interactions

157

. The 7-residue

amyloidogenic core of Aβ (16KLVFFAE22, Aβ16-22) and the 11-residue non-amyloid-β core
of -synuclein (68GAVVTGVTAVA78, NACore68-78) were tested as the model peptides in
our simulations. The aggregation of -synuclein is associated with the Parkinson's disease
149

. In the absence of CNMs, both peptides could spontaneously form amyloid fibrils in

vitro

158

and in silico

159

. From DMD simulations, we found that both peptides bound

strongly to CNTs of different structural parameters. For CNTs with small radii (i.e., large
curvatures), the peptides could form β-sheets coiled along the CNT surface where side-
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chains on one side of the β-sheets interacted with the nanoparticle (NP). The supercoil
morphology such as the angle between β-strand and nanotube axis depended strongly on
the peptide length and CNT radius, but also weakly on the CNT chirality. With increased
CNT radius, the peptide aggregates became increasingly disordered with reduced β-sheet
content. The peptides preferred to bind the large radii CNTs with increased contacts to the
NPs and decreased inter-peptide interactions. These peptides not forming β-sheets tended
to bind the CNT in a straddle conformation where all side-chains were in contact with the
flattened NP surface. Interestingly, such a surface-bound peptide conformation on the
relatively flat CNM surface had the backbone hydrogen bond donors and acceptors
exposed and sticking out of the nanoparticle surface. With excessive peptides compared to
the accessible CNM surface, we postulated that incoming peptides might form β-sheets
with those backbone-exposed peptides on the NP surface and nucleate the growth of
amyloid fibrils perpendicular to the NP surface, which was confirmed by our DMD
simulations of a graphene nanosheet with excessive peptides. Furthermore, our
computational predictions were validated by TEM imaging of NACore peptides coincubated with both SWCNT (~1.3 nm in diameter) and MWCNT (~ 110-170 nm in
diameter, approximating a flat surface). With 1:1 mass ratio, NACore rendered SWCNT
more suspended by coating the nanotubes and the observation of isolated amyloid fibrils
was minimal. In the case of MWCNT, many fibrils were found to grow out of the nanotube
surfaces as computationally predicted. Hence, our results provided not only new insights
of hybridizing CNMs with amyloid peptides and offered a novel approach to control the
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morphology of CNM-induced amyloid assembly by tuning the surface curvature, peptide
sequence length, and molecular ratio between peptides and available CNM surface area.
Results and Discussion
We investigated the effects of CNT chirality and curvature on amyloid peptide selfassembly in DMD simulations. We performed aggregation simulations of 20 Aβ16-22 or
NACore68-78 peptides in the presence of different chiral CNTs with a similar diameter of
~7.6 Å (i.e., zigzag, chiral, and armchair) and also chiral CNTs with different radii ranging
from 2.0 to 28.2 Å (R0 ~2.0 Å, R1 ~3.8 Å, R2 ~7.6 Å, R3~10.7 Å, R4~14.2 Å, and R5~28.2
Å). In our simulations, we kept the CNT surface area constant by adjusting their heights
while maintaining the total volume to ensure the same peptide concentration (Methods).
For each molecular system, 50 independent simulations each lasted 400 ns were performed
to ensure sufficient sampling. In each independent simulation, 20 peptides were initially
placed randomly around the CNT with different initial inter-molecular distances and
orientations. All simulations were performed at 300 K with the CNT kept static and
peptides free to undergo conformational changes as well as interact with other molecules.
The effect of CNT chirality on amyloid peptide self-assembly
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Figure 6-1. Self-assembly of amyloid peptides in the presence of different chiral CNTs.
(A) Typical snapshot structures of peptides forming β-sheet supercoils on the surface of
CNTs, where NACore (purple) and Aβ (green) were shown in cartoon representation. The
distribution of angles between β -strands and CNT axis were computed for the selfassembly of NACore (B) or Aβ (C) in DMD simulations.
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Figure 6-2. Typical DMD simulation trajectories in terms of potential energy and number
of inter-peptide backbond hydrogen bonds. For illustrate purpose, we showed one out of
50 independent trajectories of (A)(C) 20 NAcore or (B)(D) 20 Aβ in the presence of
different chiral CNTs.
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Figure 6-3. Secondary structure of NAcore and Aβ in the presence of CNT. (A) Secondary
structure of each NAcore residue in the presence of 3.8 CNT (upper) and 5.6 CNT (lower).
(B) Secondary structure of each Aβ residue in the presence of 3.8 CNT (upper) and 5.6
CNT (lower).
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Figure 6-4. The residue-wise inter-peptide contact frequency maps of NAcore and Aβ in
the presence of different chiral CNTs. (A) Contact frequency map of NAcores’ backbonebackbone (upper) and sidechain-sidechain (lower) in the presence of 3.8 CNT (left) and
5.6 CNT (right). (B) Contact frequency map of Aβs’ backbone-backbone (upper) and
sidechain-sidechain (lower) in the presence of 3.8 CNT (left) and 5.6 CNT (right).
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In the presence of CNTs that had similar diameters of ~7.6 Å but with different
chirality, both NACore68-78 and Aβ16-22 fragments could self-assemble into β-sheet
supercoils wrapping around CNT surfaces (Fig. 6-1A). Using the last 200 ns of all
independent simulation trajectories where steady states were achieved in our simulations
(i.e. representative trajectories shown in Fig. 6-2), we computed the secondary structure
contents of NACore68-78 and Aβ16-22 in the presence of CNT (Fig. 6-3). All the amyloid
peptides mainly adopted either β-sheet or random-coil structures. The inter-peptide contact
frequency maps among side-chains or main-chains of individual residues (Fig. 6-4)
suggested that Aβ16-22 fragments preferred to form in-registered anti-parallel β-sheets (Fig.
6-4B) due to opposite charges of K16 and E22 at both termini, consistent with our previous
simulation result

160

. NACore68-78 formed both in-registered anti-parallel and parallel β-

sheets (Fig. 6-4A), likely due to its relatively even positioning of hydrophobic valine along
the sequence.

Figure 6-5. Binding probability of NAcore and Aβ with CNT. (A) Binding probability of
each NAcore residue with CNT and average binding probability shown in dash lines. (B)
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Binding probability of each Aβ residue with CNT and average binding probability shown
in dash lines.

To characterize the morphology of self-assembled β-sheet supercoils on CNT
surfaces, we computed angles () between CNT axis and the local β-strand directions at
each β-strand residue, where the vector connecting Cα atoms of two neighbor residues
denoted the local β-strand axis (Fig. 6-1A). Using the last 200 ns of all trajectories, the
histograms of the computed  angles (Fig. 6-1B,C) suggested that both NACore68-78 and
Aβ16-22 had higher propensity to form β-sheets on the surface of chiral CNTs (e.g., CNTs
(8, 3) and (6, 5) in Fig. 6-1B,C) with higher peaks that than the zigzag CNT (10, 0). With
CNTs of different chirality, orientation of the 11-residue NACore68-78 β-sheets had peaks
at  ~ 45o-50o, while 7-residue Aβ16-22 β-sheets had peaks at  ~ 62o-72o. In the case of
Aβ16-22, there were five consecutively hydrophobic residues, 17LVFFA21, which induced a
strong hydrophobic interaction with CNT, especially the π-π stacking between aromatic
groups of Phenylalanines (F) and CNT with highest binding probabilities as shown in Fig.
6-5. To maximize the contact with CNT by burying the central hydrophobic FF region, the
peptides in a rigid β-sheet conformation tended to align perpendicularly to the CNT axis
with a relatively large  angle (Fig. 6-1A to the right). The resulted β-sheet supercoils had
larger pitch length. On the other hand, NACore68-78 had multiple hydrophobic Valines (V)
positioned approximately evenly along the sequence with high binding probabilities the
CNT (Fig. 6-5). To optimize the binding of each peptide in the β-sheet with the CNT,
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NACore68-78 preferred to align parallel to CNT with a smaller  value and the formed βsheet supercoils had a shorter pitch length (Fig. 6-1A on the left). Therefore, both Aβ16-22
and NACore68-78 can self-assemble into in-register β-sheet supercoils onto the surface of
CNTs with radii ~7.6 Å with a weak preference to armchair and chiral CNTs. Distributions
of hydrophobic and aromatic residues along the peptide sequence determines the
morphology of the supercoils, such as the pitch lengths.
The effect of CNTs with different radii on amyloid peptide self-assembly

Figure 6-6. Self-assembly of amyloid peptides in the presence of CNT of different radii.
(A) The distribution of angles between CNT axis and β-strands for the assembly of 20
NACore with CNT of different radii, ranging from R0 ~2.0 Å, R1 ~3.8 Å, R2 ~7.6 Å,
R3~10.7 Å, R4~14.2 Å, to R5~28.2 Å. (B) The corresponding typical snapshots for CNT
of different radii were shown. Similar results for Aβ were shown in panels (C) and (D).
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Aggregation simulations of both peptides in the presence of chiral CNTs with
various radii were performed to examine the curvature effect of CNTs on peptide selfassembly. Using the equilibrated simulation trajectories, the distribution of  angles
between β-strands and CNT axis was computed for different molecular systems (Fig. 6-6).
As shown in Fig 6-6A, the  angle distributions was shifted from 50o to 37 o as the radius
of CNT increasing from ~2.0 Å to ~14.2 Å (Fig. 6-6A). Meanwhile, the probability of
forming β-sheets decreased with increasing CNT radii as indicated with by typical
snapshots from simulations (Fig. 6-6B). There was no obvious β-sheet formed when the
radius increased to ~28.2 Å, and the peptides adsorbed to the CNT surface were mostly
coils. It is interesting to notice that NACore68-78 self-assembled into barrel-like structures
around the narrowest CNT (e.g., R0 ~ 2.0 Å, Fig. 6-6B to the left). Such barrel-like
structures in the presence of ultra-thin CNTs were also observed using all-atom molecular
simulations with explicit solvent161. Similarly, as the radius of CNT increased, the
propensity of Aβ16-22 forming β-sheets was also significantly decreased (Fig. 6-6C, D). The
β-sheet rich aggregates were only observed in small radii CNTs with R0 ~2.0 Å and R1
~3.8 Å, and the corresponding average -angles were ~65 o and ~67.5 o, respectively.
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Figure 6-7. Thermodynamics analysis of NACore assembly in the presence of CNTs of
different radii. (A) The two-dimensional potential of mean force as a function of the
number of residues binding CNT and the number of residues adopt β-sheet (top) or coil
(lower) per peptide. CNT radii increased s from R1 to R4. (B) Typical snapshots from
corresponding simulations illustrated the loss of β-sheet super-coil structures and the
transition from β-sheet to coil as CNT radius increases. Peptides corresponding to different
free energy basin in panel (A) were highlighted by arrows.
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To further understand the thermodynamics of peptide self-assembly on the surface
of CNTs, we computed the two-dimensional potential of mean force (2D-PMF) – i.e., the
self-assembly free energy landscape - as the function of the number of NACore68-78
residues binding with CNT and also the number of residues in β-sheet or coil conformations
(Fig. 6-7A). All the 400 ns trajectories from 50 independent simulations were used to
capture the early steps of CNT adsorption and conformational conformation. In each case
of CNTs with various radii, two energy basins were identified – where a β-sheet-rich basin
(denoted as R1-1, R2-1, R3-1, and R4-1 in Fig. 6-7A with ~6-9 out of 11 residues adopting
β-sheet conformations) had only a relatively small number of residues binding CNT (~4-6
out 11 total residues), and a coil-rich basin with a large number of residues binding CNT
(~7-11 out 11 total residues, labeled as R1-2, R2-2, R3-2, and R4-2 in Fig. 6-7A). In typical
self-assembled structures with CNTs of various radii (Fig. 6-7B), peptides corresponding
to each of the two energy basins were highlighted. Peptides either formed β-sheets via
inter-peptide hydrogen bonding but allowing at most half of the residues binding CNTs
(e.g., top inset in Fig. 6-7B), or adopted coil conformations with all residues able to interact
with CNTs (e.g., bottom inset in Fig. 6-7B). With increasing CNT radii, NACore68-78
preferred to interact with the flat CNT surface and adopt coil conformation with high
translational entropy, and the transition from β-sheet dominated configurations to coils
accompanied the loss of β-sheet supercoils (Fig. 6-6B).
Peptides form β-sheets either laterally or vertically on the flat graphene nanosheets
Examination of coil conformations of NACore68-78 on the relatively flat surface of
CNT with large radii (Fig. 6-7B) indicated that these peptides tended to bind the CNT in a
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straddle conformation, where all side-chains were in contact with the flattened NP surface.
Although classified as the coil conformation because of the lack of backbone hydrogen
bonds, the corresponding peptide conformations were rather ordered and highly extended,
which were stabilized by extensive side-chain interaction with the CNT surface. Backbone
hydrogen bond donors and acceptors were exposed and sticking out of the NP surface.
With excessive peptides compared to the accessible surface area, incoming peptides might
form β-sheets with those backbone-exposed peptides on the NP surface and nucleate the
growth of fibril-like β-sheets perpendicular to the NP surface.

Figure 6-8. The growth of β-sheets by increasing of number peptides on the surface of
graphene nano-sheet. The distribution of angle between graphene surface norm and
elongation vectors of neighbor β-sheets were computed from consecutive simulations
where the number of NACore peptide were added up to 30 with the increment of 5.
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Test the hypothesis, we used graphene nanosheets as the limiting case of flat CNM
surfaces and monitored the process of NACore68-78 self-assembly with increasing number
of peptides added to the system in DMD simulations. After initial equilibrium simulations
with five peptides in the presence of graphene nanosheet, we added five new peptides to
the simulation system every 50 ns. We stopped the simulations after 30 NACore68-78
peptides were introduced into the system in excess of the available graphene surface. As
expected, the peptides were able to form β-sheets with the elongation direction either
parallel or perpendicular to the surface (e.g., insets of corresponding snapshots in Fig. 68). To quantify the directions of β-sheets, we computed the angle (γ) between the graphene
norm and local β-sheet elongation directions at each hydrogen-bonded residue pair, defined
as the vector connecting Cα atoms of the corresponding two residues. The histograms of γangles average over time and independent simulations were computed at different stages
(Fig. 6-8). The large angles near 90o corresponded to β-sheets growing collaterally along
the graphene surface, while the small angles near 0o were β-sheets with elongation
directions along the nanosheet norm. With up to 10 peptides, there were nearly no obvious
β-sheets formed on the surface, consistent with previous simulation results that the
decreasing CNT curvatures induced peptide in random-coil dominated configuration.
When additional NACore68-78 peptides were added, β-sheets started to emerge due to
increased inter-peptide interactions. Indeed, there were two peaks around ~90o and ~20o,
respectively, confirming the hypothesis of β-sheet growth both collaterally and vertically
to the graphene nanosheet surface. Especially with excessive peptides from 25 to 30 total
peptides, the increase of the peak around 20 degree was more than doubled, suggesting the
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predominant growth of β-sheets vertically. Hence, by tuning CNM surface curvature and
the ratio of peptide with respect to the available adsorption surface area, the growth
direction of β-sheet might be controlled and pave the way for the design of high-order
hybrid peptide-CNM nanostructures.
Conclusion
In sum, we applied atomistic DMD simulation to systematically study the selfassembly structure of two types of peptide fragments, Aβ (16KLVFFAE22) or NACore
(68GAVVTGVTAVA78), in the presence of different CNMs in order to determine the
physicochemical determinants in terms of different protein sequences, CNT chirality, and
CNM curvatures. Due to strong hydrophobic interactions between amyloid peptides and
CNT, both Aβ and NACore could self-assembled into in-registered β-sheet supercoils on
the surface of small radii CNTs. The pitch length of the supercoil is mostly determined by
the peptide sequences in terms of the position of hydrophobic or aromatic residues, the
CNT radii/curvature, the relative ratio of peptides with respect to the available surface area,
and also weakly on the chiralityWith increased CNT radii and correspondingly decreased
curvature, peptides adsorbed to available CNT surface tended to form coils instead of βsheets, losing the ability to form β-sheet supercoils. Interestingly, with excessive amyloid
peptides with respect to available surface areas of large radii CNTs (e.g., MWCNT) or flat
graphene nanosheets, fibrillar aggregates could be nucleated vertically to the NP surface in
silico. Hence, our study offered a mechanistic insight to peptide self-assembly on CNMs
with different peptide sequences and CNM geometries, and should prove valuable for the
design of high-order hybrid peptide-CNMs nanostructures.
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Materials and methods
Discrete molecular dynamics (DMD) simulations
DMD is a special type of molecular dynamics algorithm where conventional
continuous inter-atomic interaction potential functions are replaced by optimized step
functions

162,163

. A comprehensive description of the atomistic DMD algorithm was

published elsewhere.27 In brief, the united-atom model represents all molecules where all
heavy atoms and polar hydrogen atoms are explicitly modeled and an implicit solvent
model was adopted to capture the solvent effect. Inter-atomic interactions included van der
Waals, solvation, electrostatic and hydrogen bonds. The solvation energy was estimated
according to the Lazaridis-Karplus implicit solvent model, EEF1

164

. The distance- and

angular-dependent hydrogen bond interaction was modeled using a reaction-like algorithm
41

. Screened electrostatic interactions between formal charges were computed by the

Debye-Hückel approximation, where a Debye length of 1 nm was used by assuming a water
dielectric constant of 80 and a monovalent electrolyte concentration of 0.1 M. The
Anderson’s thermostat 165 was used to maintain constant temperature.
Simulation system setup and Analysis
The initial structural coordinates for NACore68-78 and Aβ16-22 were obtained from
protein data bank (PDB). CNTs and graphene structures were generated from visual
molecular dynamics (VMD)

166

. For the chirality effect on peptide self-assembly, zigzag

(n=10, m=0), armchair-like (n=6, m=5), and chiral (n=8, m=3) CNTs with the diameter of
~7.6 Å were included. For the effect of varying radii, a battery of chiral CNTs (an angle of
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~15o) with radii (R) and height (H) ranging from R0 ~2.0 Å, H0 ~120.0 Å (n=5, m=2); R1
~3.8 Å, H1 ~100.0 Å (n=8, m=3); R2 ~7.6 Å, H2 ~76.9 Å (n=16, m=6), R3 ~10.7 Å, H3 ~59.6
Å (n=22, m=8); R4 ~14.2 Å, H4 ~47.4 Å (n=29, m=11), to R5 ~28.2 Å, H5 ~47.4 Å (n=58,
m=22) were used such that the total surface area was approximately the same. For each of
CNTs with different radii, 20 peptides were modeled to study their self-assembly in the
presence of one nanoparticle. To maintain approximately the same peptide concentration,
simulation box with 100×100×130 Å3, 100×100×130 Å3, 122×122×81 Å3, 144×144×61
Å3, 161×161×49 Å3, 151×151×49 Å3, were used for CNTs with radius equal to R0, R1, R2,
R3, R4, and R5 correspondingly. The simulation box dimension for graphene and peptide
was 61×61×70 Å3. For each molecular system, 50 independent simulations with different
initial inter-molecular distances and orientations were performed at 300K. Each simulation
lasted 400 ns so that an accumulative 10 μs total simulation were done for each molecular
system.
We used the dictionary secondary structure of protein (DSSP) method in our
analysis of the system secondary structure

167

. An atomic contact was defined using an

inter-atomic distance cutoff of 6.0 Å. Inter-chain peptide interactions were analyzed by the
residue-residue contact frequency. The two-dimensional potential of mean force (2D PMF)
about peptide-CNT binding was calculated according to the equation, PMF = - kBT ln P(nA,
nB), where kB was the Boltzmann constant, T corresponded to the simulation temperature
of 300 K, and P(nA, nB) was the probability of the number of residues binding CNT (nA)
and the number of residues in coil or β-sheet conformation (nB).
Experimental preparation of NACore and CNTs
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The NACore68-78 fragment, with sequence GAVVTGVTAVA, was synthesized and
high performance liquid chromatography (HPLC) purified by GenScript. Single-walled
carbon nanotube (≥90% carbon basis, 1.3 nm diameter) and multi-walled carbon nanotube
(>90% carbon basis, diameters 110-170 nm, length 5-9 μm) were purchased from Sigmaaldrich Co. LLC. The lyophilized powder of the NACore68-78 peptide was first solubilized
in 100% hexafluorosiopropanol (HFIP) (Sigma) at ∼1 mM and sonicated at 30% power
efficiency for 30 s (Qsonica Q125) to break preformed aggregation. The concentration was
then determined spectrophotometrically using a calculated extinction coefficient at 280 nm.
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